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ABSTRACT ii
ZACHARY T. KELLEHER. The cloning of the Fanconi's anemia gene. (Under
the direction of Dr. Jean-Michel Vos).
The aim of this project was to pinpoint the location and ultimately the
gene code of one of at least four possible genes of Fanconi's anemia, a
human "DNA repair" disorder. In the first part of the study, microcell-
mediated chromosome transfer, an estabUshed procedure, was used to
transfer a normal tagged human chromosome #20 (the reputed location of
the FA-A gene, carried in an A9 mouse cell line) into FA-group A
lymphoblasts and fibroblasts at which point they would be tested to see if
the uptake of this chromosome corrects two prominent manifestations of
the FA defect, namely its inherent chromosomal instability and its
hypersensitivity to DNA cross-hnking agents. Success in this venture was
elusive.
In the second part of the study, the first steps of a proven method of
gene cloning was tried involving first, the transfection of a cDNA library,
carried in an Epstein-Barr virus (EBV) vector into an FA-group B cell line,
and then pulUng out the FA-B gene from these cells by treating them with
DNA cross-linking agents and selecting for ones which have lost this
hypersensitivity. Three different methods of transfection, electroporation,
lipofection and endocytosis-fection, were tested to discover which was the
most efficient at transferring plasmid DNA into the FA group B cells. This
group, which is one of the most sensitive of the four known FA cell lines,
was transfected, in transient assays, most efficientiy via endocytosis-
fection. However, the attempt to select for long term maintenance of
plasmid DNA was unsuccessful for FA-B cells using any of the transfection
methods. However, successful maintenance of the cDNA-containing plasmid
by FA-A lymphoblasts was obtained. Modifications are being made to
circumvent the problem with the former cell line while work continues to
build on the success with the latter cell line.
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CHAPTER I: INTRODUCTION
The integrity of the genetic material of all living cells is constantly being
challenged by "outside" environmental agents such as heat, radiation or
mutagenic compounds, by DNA modifiers generated by cellular metabolismand by the inherent chemical instability of DNA.    Alterations in the geneticmaterial could, if left uncorrected, be deleterious to the cell by affecting
the replication process, in the case of cross-links between DNA strands, or
by altering important genes, by either the insertion, deletion or
substitution of base pairs within the genome.    Fortunately, cells have
developed  elaborate  and efficient methods  of repairing  altered  or damaged
DNA to combat the daily onslaught of harmful agents.
Out of the many repair systems, the most classic is "excision repair"
which involves a number of factors acting cooperatively to restore altered
DNA to its undamaged form.    These factors must perform a number of
functions including recognizing the damaged DNA, binding to the lesion,
"nicking" or cutting the DNA backbone around the lesion, excising or
removing the nucleotides between  the nicks, replacing  the  nucleotides,  and
finally ligating the newly synthesized DNA to the old (figure 1).    At the
present time this system is best characterized in procaryotes, especially in
the UvrABC repair in the bacteria Eschericia coli. where many of the DNA
repair genes have been identified and cloned (38).
While excision repair can be used to repair damage to one strand of
DNA, more complicated mechanisms, such as bypass repair and recom¬
bination, must be used to repair damage involving both strands.    For this
type of damage, the DNA lesions are bypassed during replication and then,via recombination with the homologous strand of DNA (which acts as the
new template), restored to its original form.    Though the basic mechanisms
of excision repair, such as the recognition and replacement of the damage,as well as the resynthesis of new DNA, are involved in interstrand
cross-link repair in eucaryotes, the exact mechanisms of repair as well asthe  many components involved in it remains poorly characterized(57;.The most progress in characterizing the mechanisms  and enzymes
HGURE 1: DNA EXCISION REPAIR IN PROCARYOTES
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3involved in repair in eucaryotes have come in the  study  of yeast where
many radiation inducible genes (RAD) have been found (55).
Further study on a cellular process as crucial and yet as poorly
understood as DNA repair is imperative for a number of reasons, many of
which are elucidated by Vos (57).    With the increase in potential DNA
damaging agents being released into the environment each year it is
especially important to know how these agents are affecting living
organisms on a cellular level and how these effects are handled by the
cells of the organism.    This knowledge could potentially affect treatment of
those exposed to these harmful agents as well as on the manner in which
these agents are released into the environment.    It can also help to
delineate the role of repair in the complex and pathogenic multicellular
processes such as cancer and aging.
Fanconi's anemia (FA) is a recessive, inherited genetic disease which has
been characterized as a "repair disorder" along with other defects such as
Xeroderma Pigmentosum (XP), Ataxia telangiectasia, (AT), Bloom's
syndrome (BS), and Cockayne's syndrome (CS).    The fact that it is inherited
makes it a stable system in which to study DNA repair.    The exact
mechanisms of the FA defect is unknown, though cells from FA patients
apparently are deficient in their ability to repair cross-links of their DNA
and are genetically unstable.    The defect is thought to be the result of an
altered endonuclease responsible for the initial incision  step of repair.
However, four different types of FA have been found each of which could
involve  a separate factor.
CHAPTER II: LITERATURE REVIEW
Fanconi's  Anemia.
What is Fanconi's Anemia?
Fanconi's anemia (FA) is a rare autosomal recessive disorder which is
characterized by some or many of the following: a predisposition to acute
myelegenous  leukemia  and  other malignancies,  bone  marrow  failure,
congenital  abnormalities  which include  skeletal deformities  such  as
absence   of thumb  and  radii,  intrauterine  growth  retardation,   short  stature,
hyper  pigmentation  and  pancytopenia  (18, 24, 49).
Cells from persons with FA are characterized by a higher than normal
rate of spontaneous and induced level of chromosomal breaks, a
hypersensitivity  to DNA cross-linking  agents,  an increased  sensitivity  to
oxygen and a perturbed cell cycle (3, 27, 29, 46).   The  manifestations  of
any of these defects varies widely between patients both clinically, with
differences  in the incidence, type, onset and severity of the malformations,
and biochemically, with wide variations in sensitivities to DNA damaging
agents and level of chromosomal aberrations.    There has of yet been no
correlation found between the  severity of the clinical  symptoms  and
cellular deficiencies (4).
This extreme heterogeneity of FA symptoms is a factor which must be
considered whenever analyzing data of this disorder.    It also may indicate
that the FA defect is a complicated one, involving more that just DNA
repair.    At present it is believed that there are at least four different genes
or gene parts which are responsible for the FA defect.    Through
complementation  studies,  four different complementation  groups  of FA
cells have been established, labeled, respectively, A-D (15, 52).
(Complementation groups are determined by fusing cells from different FA
patients  via somatic cell fusion  and checking  the cross-linking  sensitivity
of the subsequent products.    If there were only one gene responsible
for the FA defect then the hypersensitivity of the fused cell line would be
expected, for the most part, to be similar to that of the original cells lines
-%'- *-."T>"n-*"5S^55S*^?'^
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because each line would contribute two defective FA genes.     However,
when cells  from certain FA patients  are fused,  the  subsequent sensitivity
of the resulting cell line is similar to that of normal cells, indicating that a
correction of the defect has taken place.    This could be explained if there
were more than one defective gene or gene part involved.    The defective
gene of one cell line is masked by a normal copy of that same gene or gene
part contributed by the second cell line and vise versa.    Cells in this latter
category are said to be in different complementation groups  since they
complement each  other  and  apparently contain  different  mutations.     Cells
belonging to the former category are said to be in the same
complementation  group  since  they cannot complement each  other and
therefore  share  the  same  defect.
What are the primary characteristics of FA cells?
Though there is wide variation in the phenotype between FA cells there
are certain characteristics that are consistently found among them.     In
trying to determine how best the gene might be cloned, the most salient
features of the defect have been examined.    These characteristics can
ultimately be exploited to uncover the nature of the FA impairment and
the mutated  genetic code which underlies it.
There are five primary manifestation of the FA defect on the cellular
level.    The first and one of the most obvious is the increased rate of
spontaneous chromosomal aberrations (CA).     These were first characterized
by Schroeder in  1967 and have since been described by numerous other
researchers   (8, 15, 43, 56).    The types of aberrations seen most often are
chromatid gaps and breaks though the level of sister chromatid exchange
(SCE) has been shown normal in FA cells (35, 36).
The extent of spontaneous CAs varies between the cells of different
patients as well as in cells from the same patient over time (8, 49).
Additionally, the CA rate varies among cells in the different
complementation groups with FA-B cells demonstrating  a higher rate of
spontaneous breakage than either FA-A or FA-D cells.    FA-C cells, one of
the newest FA cells lines has yet to be characterized for spontaneous or
induced  chromosomal  breakage  (13, 15, 16).
The second is that FA cells have an increased rate of induced
chromosomal  aberrations  (over that of the  spontaneous  level)  whenever
6exposed to DNA cross-linking agents.    This is in contrast to normal cells
which  show  no  such characteristic increase when treated  with  similar
doses.    This induced rate of chromosome breakage in FA cells is one of the
most consistent features of the disease and indeed, it is used as the pre¬
eminent characteristic in the diagnosis of the disorder (4, 8, 15, 16, 43, 56).
The third most salient feature of the FA defect is the sensitivity of FA
cells to DNA cross-linking agents.    Cross-linking agents are compounds
which can intercalate into DNA, covalently linking either two adjacent base
pairs  (intra-strand cross-links)  or two base pairs  on  opposite  strands
(inter-strand cross-links).    In the process of characterizing the FA defect,
cells from FA patients have been treated with a number of different DNA-
damaging chemicals such as mitomycin C (MMC), diepoxybutane (DEB),
psoralen  and UVA  light (PUVA), cis-diamine-dichloro-platinum II  (cis-Pt
(II)),  other    mono-  and polyfunctional alkylating  agents,  nitrogen mustard,
and ionizing radiation (3, 7, 16, 27, 43, 46).   The majority of these studies
have found that FA cells have a deficiency in the repairing the damage
caused by those compounds which form DNA cross-links, though there are
studies which dispute this (19, 32, 42).    These latter studies might be
explained  by  the extreme  heterogeneity  that exists  between  the  various
FA complementation  groups, which were not characterized  in the reports
sited.    Indeed, the FA-D group, represented by the cell line HSC 62 and
most likely FA-145, has been shown to be only slightly more sensitive to
cross-linking agents than are normal cells both in the repair of these cross¬
links (40)   and survival after DNA cross-linking treatment (16, 27, 41, 60).
Additionally,  different  cross-linking  agents   work  by   different
mechanisms  and may require different repair pathways.     Thus,  the extent
of cross-linking sensitivity may vary depending on the agent used.    It has
been observed that FA cells are more sensitive to PUVA than to MMC by
an order of magnitude based on the EC 10, the effective concentration of
cross-linking agent which inhibits growth to 10% of normal, when
comparing the difference in sensitivities between normal and FA cells.    FA
cells treated with MMC are  1-11 times more sensitive than normal cells
while with PUVA the difference is 15-110 times (personal data).    It is
known  that PUVA interacts primarily with pyrymidines whereas  MMC
(and  nitrogen  mustard)  form cross-links  between  purines,   specifically  on
the Og of guanine (41).    At present it is generally accepted that while FA
'^S^^!^
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cells do have the ability to repair DNA cross-links, they do so at a lower
efficiency than normal cells (27, 40, 41).    This defect in cross-link repair
along with the genetic instability are the strongest evidence that FA as a
DNA repair disorder.
The fourth defect manifest in FA cells is their sensitivity to oxygen.
Joenje and colleagues have shown conclusively that the level of
chromosomal aberrations in FA cells is dependent on the level of oxygen in
the  ambient environment.     When FA cells  were exposed  to reduced  levels
of oxygen (0,0-5.0%) a decrease in the level of breaks was observed.
Conversely, when these cells were placed in an environment with an
increased level of oxygen compared to normal levels, an increase of
chromosomal  breaks  was  observed (29, 30).    This has lead some to propose
that the primary defect in the FA disorder is not, as generally believed, a
defect in the DNA repair system but rather a deficiency in the cells ability
to detoxify reactive oxygen species (29, 30, 31).
Finally, FA cells have disturbed cell cycle manifest in a prolonged S and
G2 phase.    Weksberg et al. (1979) have found that the increased doubling
time in FA cells is due to an increased generation time as well as a higher
rate of cell death.    Dutrillaux (1982) found that it took FA cells on average
32-40 hours to pass through one full cycle, while the time for normal cells
was 28 hours (17, 47, 60).
What is the nature of the FA defect?
Aside from the clinical aspects of the disease, the primary focus,
biochemically, on the FA disorder has been on the defect in repair, though,
as mentioned, this is not the only defect in this syndrome.    While it has
been conclusively demonstrated that FA cells are slower in their
repair of interstrand cross-links and have a higher rate of chromosomal
breakage compared to normal cells, the exact mechanism of this process
has yet to be fully elucidated though a few theories have been proposed
which find experimental support.    There has been growing evidence that
the defect in repair in FA cells involves the first incision step of the cross¬
link repair process, more specifically, that there is an alteration in one of
the endonucleases which perform the initial incision  step, retarding its
ability to do its job (21, 22, 25, 34, 41, 44).    Sakaguchi et al. (1992),
demonstrated  that a Chinese  hamster mutant (mus308),  which  is  analogous
8to FA cells in its sensitivity to cross-linking agents and its high level of
spontaneous  chromosomal  aberrations,  has  a mutation  which  results  in  an
defective endonuclease.     More specifically, Lambert et al.  (1992) have
isolated modified endonucleases from both FA-A and FA-D cells (the latter
which they refer to as FA-B).    The defective endonuclease in FA-A cells
recognizes  psoralen  intercalation's  and  interstrand  cross-links   and  takes
part in the initial incision step of the repair process.    In their studies, it
exhibited 25% the activity of the normal endonuclease.    The altered
nuclease in the FA-D cells recognizes psoralen monoadducts and has
approximately 50% of the activity of the normal endonuclease.    These
findings were later strengthened when the defects in each of these FA
groups was corrected with the insertion of the respective normal
endonuclease   (34, 44).    These finding confirm earlier studies which found
FA-A cells to be defective in the first incision step of the cross-link repair
process and that FA-D cells have a defect in the repair of monoadducts
formed by psoralen and UVA light (6, 41, respectively).
Though an  altered endonuclease may be responsible for the diminished
repair capacity in FA cells, it does not necessarily follow that the mutated
FA gene(s) codes for such an enzyme.    Such an claim would fail to account
for the observed oxygen sensitivity and cell cycle disturbance of FA cells.
At present,  no explanation has been proffered nor empirical evidence
found which might adequately account for the all of the known FA defects.
This may indicate that the mutated gene responsible for the FA defect
codes for a multipurpose enzyme and not just an enzyme involved in DNA
repair.
CLONING THE FA GENE
Reasons for cloning the FA gene.
Their are two basic routes that can be used to uncover the FA defect,
namely the biochemical approach, which focuses on the actual mechanisms
of a system and the components involved therein, as was used by Lambert
et al, (1992) and Sagaguchi et al. (1992) who examined the modified
endonucleases in FA or "FA-like" cells, or the genetic approach, which tries
to uncover the code of the mutated gene responsible for the disorder, like
Strathdee et al.  (1992) who have successfully cloned the FA-group C gene.
This project follows the latter of these routes (34, 44, 53).
9The   genetic   approach  has   the  advantage  of ultimately  discovering  the
code of the mutated gene which may lead to the discovery of the
biochemical mechanisms of the gene product, though finding the gene
doesn't guarantee discovering the defective protein.    However, if the gene
is cloned, its homology to any other known gene can be checked.    If it
shares  homology  with  other characterized  genes,  the  information  on these
genes might help to further uncover the nature of the FA defect and what
role repair plays in it.   Or, as in the case of the FA-C gene, it could turn out
to be novel or uncharacterized, in which case the discovery of the protein
and mechanism of action may be even more valuable.
A second advantage to discovering the code of the FA gene is for its
potential use in gene therapy.    If a normal copy of the FA gene could be
delivered to certain target cells in the body of a FA patient, as in systems
which are now being developed in cystic fibrosis and other diseases, this
would be an enormous benefit to those people with the disease who now
can rely  solely on bone marrow transplants for the treatment of the
disease.     There  are indeed systems like this being developed at the present
time(54).
A third advantage of using the genetic approach is that once the gene is
found, it can be used, in the case of the FA gene, for more sensitive
diagnosis of the disease.    Though the present assays, based on sensitivities
of the cells of FA patients to DEB, are adequate in diagnosing FA, more
precise determinations could be made if the gene was known.
There are two parts to this project; The goal of the first part is to
confirm the assignment of the FA-A gene to normal human chromosome
(HC) #20 by means of microcell mediated chromosome transfer (MMCT).
The successful completion of this goal would eliminate a large portion of
the human genome from consideration as a site for this gene, which stand
as yet, uncloned.    The goal in the second part of the project is the actual
cloning of the FA-B gene using a new system used to clone the FA-C gene.
The successful completion of this project would unlock the code of a second
FA gene and shed additional light on the FA disorder.
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Project I:  Confirming the putative location of the FA-A  gene.
Justification
In looking for effective methods in uncovering the location of the FA
gene, one strategy is to examine the paths taken by those exploring other
"DNA repair disorders" such as Xeroderma Pigmentosum (XP), Ataxia
telangiectasia (AT), Bloom's Syndrome (BS), or Cockayne's Syndrome (CS),
some of which are farther along in the cloning of the respective genes (1).
There are three key studies involving other "DNA repair"  disorders
which provided the basis for this project.    In the attempt to find the
chromosomal location of an AT gene, Gatti et al.    (1988) performed a
genetic linkage analysis in 31 families with AT group D (AT-D) affected
individuals.    From this study they estimated the AT-D gene to be on
chromosome  11  q22-23 (23).    Following this study, Komatsu (1990)
inserted a normal human chromosome 11 (HC 11) into AT-D cells via
MMCT and achieved correction of the defect, thus confirming the previous
study (33).    In earlier studies, the MMCT procedure was also used to
correct the XP-A defect by insertion of a normal, however, transposed
human  chromosome  (50).
As with the Gatti study, Mann et al., (1991) performed a genetic linkage
study on 34 families which had members affected with FA and estimated
that the FA-A gene is located on HC 20q (39).    The next step in uncovering
the chromosomal location of the FA-A gene, following the path taken with
the AT-D research, was to insert HC 20 into FA-A cells to determine if
correction  takes  place.
Approach
To test the hypothesis that the FA-A gene resides on HC20, MMCT was
used to transfer HC20 into FA-A cells.    MMCT is an established method of
chromosome transfer and is used often to transfer human chromosomes
into rodent cell backgrounds or visa versa for the purpose of gene
complementation   and  for  chromosome  mapping  {20, 45, 48, 59).   In the
MMCT procedure, microcells, or enucleated sacs containing various
numbers of chromosomes, are formed by the addition of a mitotic blocking
FIGURE 2: MICROCELL-MEDIATED CHROMOSOME TRANSFER. 1 1
Donor    Cells Recipient     cells
i
i
A9 mouse cells with normal
human chromsome #20 tagged
for neomycin resistance
Expose to colcemid
for 48 hours
Blocked in mitosis,
microcells form.
Place cells in cytochalasin B.
Spin at 12K for 1 hour.
FA-A cell line. Both # 20
chromosomes have recessive
FA genes.
Microcells break free of cell
membrane, pellet out.
8u
Su
3u   V
V
Purify microcells by gently pushing
them, in a syringe, through a filter
stack with 8, 5 and 3 um pore size
filters. Collect in 15 ml tube.
PH '^^'v /-f
Mix purified microcells with
PHA and add to FA cells.
Remove PHA and add PEG to fuse
microcells and FA cells.
\
PEG
Wash with media-
Resistant cell line should have
three #20 chromosomes; 2 of
which should have defective FA
genes and one which should
carry the normal complement to
that gene.
Wash FA ceils with
unsupplemented media.
N/
©
I
^
G418
Wash cells in media.
Add G418 (neomycin) to select
for FA cells which recieved
chromosome #20.
©)(©
^
Test to see if FA defect is corrected.
12
agent, such as colcemid, to the cells for an extended period of time (24-72
hours, see figure 2).    These micronuclei are then collected by first placing
the cells in a solution of cytochalasin B, an agent which destabalizes the
microtubules, causing a loosening of the cell membranes, then  spinning
them at a high velocity whereby the microcells escape the confines of the
cell membrane and pellet out.
The microcells are purified via filtration then transfected into a given
cell line by first treating them along with the recipient cells with
phytohemoglutinin (PHA) which helps the microcells to attach to the
recipient cells, and then with polyethylene glycol (PEG) which weakens the
cellular membrane and allows the microcells and their contents to be taken
up by the cells.    There is usually a selectable marker, such as a hygromycin
or neomycin resistance gene, on the inserted human chromosome.    This
allows for the selection of cells which take-up this chromosome.    In this
experiment, a mouse cell line containing a single human chromosome (#20)
tagged for neomycin resistance, was used as the donor cell line to be fused
to one of four different cell lines characterized as belonging to FA group A,
Once this was successfully completed, the next step would be to test the
cells for correction of the FA defect by observing the spontaneous and
induced levels  of chromosomal breakage as well as the cross-link
sensitivity of the new cell line.    Correction of both of these parameters
would be a positive indication that the FA-A gene was on HC 20.
Correction of only one of these parameters, a partial complementation,
would indicate, among other things, that part of the FA gene was missing
from the inserted chromosome or that there was an overexpression of a
protein which compensates for the one defective in the FA system.    A
failure to achieve correction in either of these two parameters might
indicate that the FA-A gene is located on another chromosome though this
result might also be observed if the gene was masked or altered or had
become  disassociated  from  the  marker.
Project Two: The Cloning of the FA-B Gene
The scope of the second project was wider and more involved than that
of the first.    In this project the objective was to recover and characterize
an FA gene, rather than the merely determine the its chromosomal
location.
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Justification:
Over the past decade there have been numerous attempts to clone the
FA gene(s) and many methods using a variety of DNA types have been
used, ranging from transfecting FA cells with wild type genomic DNA (10),
injection of HeLa mRNA into FA cells (14), transfecting total mouse
genomic  DNA  (13),    and by studying non-human systems which carry
defects analogous to FA such as with the Chinese hamster mutant V-H4 (2,
44).   However, none of these studies were able to uncover an FA gene.
Recently though, the FA-C gene was cloned using a novel method of
transferring a cDNA expression library using the Epstein-Barr virus as a
vector, into a FA-C lymphoblastoid population and selecting out the
plasmid which corrects the FA sensitivity to DNA cross-linking agents.
This method, with minor variations, serves a the basis for the cloning of
the FA-B gene (52, 53).
The cloning strategy used by Strathdee et al. (1992) has a number of
advantages to the other methods sited.    The most important of which
involves the use of the mini-Epstein-Barr virus (EBV) as a vector to insert
cDNA into cells.    The mini-EBV contains only the essential genes needed for
its maintenance inside a cell line and is only a fraction of the size of the
normal EBV (10-20 kb compared to approximately 170 kb), making it
small enough to efficiently transfect into cells using standard methods of
transfection.    Unlike most plasmids, the mini-EBV (as well as the EBV) can
be maintained as an episome inside mammalian cells as long as it is in the
presence of the protein EBNA-1  and contains the origin of replication (oriP)
driven by a promotor.    Episomal plasmids can then be easily recovered
using   standard   laboratory   techniques(52j    in contrast to linear plasmids
which are integrated into the genome and thus are more difficult to pull
out.    Linear plasmids, when integrated, may also disrupt the expression of
crucial genes required for the proper functioning of the cell, especially if it
is randomly integrated.    Upon integration, plasmids may also be
rearranged or altered (53).   Once retrieved, episomal plasmids  can  then be
isolated and amplified by shuffling them into bacteria.    The cDNA
contained in the plasmids can be isolated by a simple enzyme digestion at
the restriction sites flanking the cDNA sequence (see figure 3).
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Approach
Choosing the cell line.   Why FA-B.
At the  start of the study, three complementation groups remained to be
cloned, FA groups A, B and D, with group C being cloned earlier by
Strathdee et al., 1992 (53).   The cloning of FA group D was rejected
because it is the least sensitive of the four FA cell lines to cross-linking
agents, making it difficult to differentiate when the cell line has been
corrected and one of the only known FA-D cell lines, HSC 62, a
lymphoblastoid cell line, has a doubling time of approximately twice that
of the other FA cell lines (personal data).
FA group A was not totally ruled out though it is known that more than
one other laboratory is pursuing the cloning of this gene.    FA group B was
then chosen based on these and other reasons, one of which is that, unlike
FA-D cells, it has a cross-link sensitivity (based on the EC 10) 10-100 times
greater than normal cells, depending on the agent used.    This makes it
easier,  for  selection purposes,  to differentiate  between corrected  and
uncorrected cells.    It is, next to FA-C cells, the most sensitive of the
remaining  complementation   groups  (personal data, 52, 53).   FA-B cells
were shown as well to have the highest rate of spontaneous and induced
chromosomal aberrations than either FA-A or FA-D cells (15, 16).
Obtaining a cDNA library.
There were two ways to acquire a complementary DNA (cDNA) library.
The first was to construct one by collecting the total messenger RNA
(mRNA) of a normal cell line and then synthesizing the complementary
strand of each mRNA segment.    In this way, the coding sequence for each
gene that is expressed in the cell can be collected.    These segments of cDNA
can then be inserted in an mini-EBV vector, with each plasmid taking up
one piece of cDNA.   So in a large number of mini-EBV vectors, a whole
cDNA library can be constructed.    The other option was to purchase a cDNA
library that was commercially manufactured.    For the sake of time, the
latter option  was chosen.
Transfection   Methods
Once a cDNA library, contained in an EBV shuttle vector, was obtained
then the major task was to find an efficient method of transferring the
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plasmid DNA into the cells.    Enough cells must take-up the plasmid to
insure that the entire library is expressed.    The most common way to
transfer plasmid DNA into cells is by transfection and in this project three
different  transfection   methods  were  employed;   electroporation,   lipofection
and   endocytosis-fection.
Electroporation is a common method to fuse cells and to insert pieces of
DNA into cells.    Media containing cells and the DNA are placed into a small
cuvette or chamber with a metal plate on two opposing sides.    The
chamber or cuvette is placed in an electric field, with a positive charge on
one plate and negative on the other, where it receives an electrical current
of a given voltage and capacitance for a short duration.    During the passage
of an electrical current, all negatively charged particles in the chamber will
migrate to the positive charged plate.    The speed of the migration depends
on the mass of the particles with the smaller particles, such as the
negatively charged plasmids, migrating at a much greater speed than the
more massive cells.    Thus the plasmid DNA "shoots" through the cells like a
bullet, remaining in a certain portion.
Lipofection is a method of transfecting DNA by joining the negatively
charged DNA with the cationic liposome mixture.    The DNA-liposome
complex fuses easily with mammalian cell membranes where it is taken up
by the cell.
Endocytosis-fection is a relatively new  system of transfection  involving
the association of DNA with adenovirus and the ligand transferrin, two
components which have receptors on the membrane of most cells, and
adding this complex to cells where it binds to receptors on the cell surface.
Once attached to the membrane, the DNA complex is efficiently taken up
by the cell via endocytosis.    Inside the cell, a component of the adenovirus,
thought to be the capsid protein, induces a drop in the pH which disrupts
the endocytotic membrane, allowing any DNA associated with it to escape
and sparing it from degradation by the endocytotic enzymes.    The DNA is
then free to migrate to the nucleus (11, 12, 58).
This system has been found to be extremely efficient for transfecting
DNA into mammalian cells, up to 100% in some cell lines (11, 58).    There
has of yet been no reports of the successful use of this method to stably
transfect plasmid DNA, possibly indicating a problem in doing so.    Indeed
this replication-defective adenovirus  may be deleterious  to the  survival of
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the  cells  either because  it is  not totally replication-defective  or because  it
becomes   replication-competent  via  recombination   with   endogenous   virus's
in the host cell.    It has also been postulated that a component of the virus,
the penton protein of the capsid, is toxic to mammalian cells (9, 12).
Experimental   Plan.
Once the best transfection method has been found and an EBV-cDNA
shuttle vector and FA cell line been obtained, then an entire cDNA library
must be inserted into an FA cell population.    The number of genes in the
human genome has been estimated to be 1.0 x lO^.    Therefor at least this
many cells must be successfully transfected in order to insure that a
majority of the library is expressed in the cells.    To greatly increase the
chances of having the entire library expressed and in high enough
numbers to pull out the FA gene, at least ten times that amount or 10^
clones should be obtained.    Since the plasmid has a gene conferring
hygromycin resistance,  the cells which take-up the plasmid can be selected
by treating with hygromycin B and pulling out the survivors.    Once the
survivors  of the  hygromycin  treatment have  been  obtained  then  the
corrected cells containing the FA gene can be selected for by treating
the population of cells with first one and then another DNA cross-linking
agent at doses which are lethal to the majority of FA cells but not to
normal cells.    Cells which survive treatments with both cross-linking
agents will most likely contain a plasmid with the cDNA containsing the FA
gene.
To confirm that the FA gene has been found, the plasmids from a large
population of these cells must be extracted and then transfected into E.
coli where each bacteria will take-up only one plasmid.    Mini-plasmid
preps can then be performed to obtain large numbers of each individual
plasmid.    Each separate plasmid can then be run on an agarose gel to
determine its  size and to ultimately determine how many distinct plasmids
there are.    The individual plasmids, starting with the ones recovered in the
largest number can be introduced back into the FA cells and can be
selected once again with the two DNA cross-linking agents.    Plasmids
conferring resistance to these agents after this second round of selection
should contain at least some portion of the FA gene of interest (figure 3).
Strathdee et al., found that in the pool of plasmids recovered form the two
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cross-linking  treatments,  only  a  small  number  of them  actually  corrected
the defect.     The others were "passenger" plasmids that were maintained
along with the correcting plasmids.    This is due to the inherent stability of
the EBV episomal plasmid in the presence of EBNA-1.
The final step would be to recover the cDNA in all the individual
plasmids  that conferred  resistance  by  enzyme  restriction,  and  sequencing
them, noting consensus sequences contained in all of the plasmids.
FIGURE 3: THE CLONING SCHEME OF THE FA-B GENE. 1 8
Q    ^  -      EBV plasmids each with a
0*P ^     segment of   the cDNA library.
After 2cd selection,
sequence cDNA.
Nk      Transfect plasmids into FA cells.
Re-transfect clones back into
FA cells to see which ones
correct the defect.
hygromycin B Select for hygR cells
12  3  4
Cut out cDNA portioon of plasmid:
Run on a gel to determine number of
separate clones.
MMC- Treat cells with XL agent T
m
Clone #
DM0
12    3    4
PUVA
Grow up each clone.
Extract pure plasmid. T
(®) (®)
>      Extract plasmid.
Transfect into E. coli.
m
Only cells which can adequately repair
.'s will survive, i.e. cells which have
'e plasmid containing the cDNA with the
FA gene.
19
Chapter III: MATERIALS AND METHODS
Cell lines and cell cultures.
The A9 mouse cell line with human chromosome #20 (HC20) tagged
with neomycin resistant gene was obtained by Dr. R. Misra.    HSC's 72, 99,
230, and 62, human, EBV transformed lymphoblastoid cell lines from FA
groups A, A, B and D respectively, HSC 1199-11-2, a human SV40
transformed FA fibroblast, and HSC 92 and 93, normal human
lymphoblastoid cell lines, were the generous gift of Dr. Manual Buchwald,
(Hospital for Sick Children, Toronto, Canada).    GM6914A, a human SV40
immortalized  fibroblast,  and  GM1309B,  a primary  human fibroblast,
officially classified as belonging to FA group A, were purchased through
the Human Genetic Mutant Cell Repository (Camden, N.J.).
Media and Cell culture
The A9 mouse cell cultures were maintained in RPMI 1640, (Gibco)
supplemented with  10% fetal bovine serum (FBS),  100 ug/ml glutamine
and  100 ug/ml penn-strep and maintained in 800 ug/ml G418  (Gibco).
They were split 1:10 - 1:15 every 5-6 days.
The FA lymphoblast cell lines HSC 72, HSC 99 and HSC 230 were main¬
tained in RPMI  1640 media and supplemented with 10% FBS or 10% bovine
calf serum (BCS) as well as glutamine and penn-strep.    They were split 1:8
every 5-6 days.    The normal lymphoblast cell lines HSC's 92 and 93 were
maintained in RPMI 1640 media supplemented with 10% FBS or BCS as well
as glutamine and penn-strep and were  split  1:10 every 5-6 days.
The transformed fibroblast cell line, GM6914A was maintained in Eagles
minimal essential media (EMEM, Gibco) and supplemented with 10% FBS,
glutamine and penn-strep.    They were split  1:10 every 5-6 days.
GM1309B  was maintained in EMEM supplemented with  10% undialysed
FBS  with  glutamine, penn-strep and non-essential amino  acids  and was
split 1:5 every 5-6 days.    The FA fibroblast cell lines, HSCl 199-11-2 was
maintained in EMEM media and supplemented with 10% FBS as well as
glutamine and penn-strep.     They were split  1:4 every 6-7  days.
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Plasmids   used:
The lacZ expression vector, pH200 was constructed by T. Sun of the Vos
lab and is a mini-EBV plasmid containing the genes, oriP, the origin or
replication in  mammalian cells which contributes  to the  stable
maintenance of the cell as an episome, ori lyt, the origin or replication in
mammalian cells during the lytic cycle, hygr,    hygromycin resistance gene
for selection in human cells, and ampf, the ampicillin resistance gene for
selection in bacterial cells, all of which are driven by an SV-40   promotor.
pH210 is the same construct as pH200 with the addition of lacZ gene
driven by the SV40 promotor.    pH250 is a similar construct as pH200 but
with the addition of a CMV promotor and the lacZ gene (figure 4).
pDR2 is a commercial EBV plasmid containing a cDNA library (Clontech
Inc.) derived from human placental cells.    It contains an oriP, Col El ori, for
replication in E. coli cells, EBNA-1, also for stable maintenance of the
plasmid as an episome, hygr for selection in human cells, ampf for
selection in bacteria, a cDNA insert and an RSV-LTR,   the Rous-Sarcoma
virus promoter for the expression of the cDNA in mammalian cells, (figure
5).
METHODS: Project One:
Microcell-mediated   chromosome   transfer   procedure.
The MMCT procedure is based on the protocols presented by Fournier,
(1981), Saxon et al., (1985), and Sanford and Stubblefield, (1986) and Dr.
B. Weisman (unpublished) and can be seen in figure 2 (20, 45, 48).   It can
be broken down into four basic parts, consisting of the following:
1. Recipient and  donor cell preparation.
Approximately  1.0 x  106A9 cells were seeded into each of six T-25
Nunclon flasks four days prior to the day of fusion to be 80% confluent 2
days before the fusion.    At this time colcemid was added at concentrations
ranging from 0.005 - 0.2 ug/ml.    2.0 x 10^ GM6914A cells or 3.0 x 106
GM1309B cells were seeded into a each of two 100 mm tissue culture
plates (Falcon) 2 -3 days prior to the fusion so that they would be 80%
confluent on the day of fusion.    One dish received the MMCT treatment
with the microcells while the other dish received the MMCT treatment
with no microcells.   FA lymphoblast were seeded at 2.0 x 10^ cells per 100
mm dish 3 days prior to the fusion day so that they would be in log
21
A)
FIGURE  4!   MTNT-ERV  EXPRESSION   VECTORS
B)
PBR322
amp R    ORI
EBVTR
EBV
on lyt
pH200
HSVTK
prrxnonx
PBR322
amp R    ORI
hygH
HSV polyA
BamHI
EBV
on P
PBR322
amp H   ORI
C)
HSVTK
promotor
hygR
HSV polyA
promo lor
BamHI
lacZ SV40
pdyA
EBVTR
PH250
HSV polyA
promoior
HSV TK promoior
BamHI
lacZ CMV
polyA
Figure 4: Three mini-EBV plasmids:" A) pH200, a non-lacZ containing mini-
EBV plasmid, B) pH210, the same construct as pH200 except a SV40 driven
lacZ gene has been inserted at the BamHI site, and C) pH250, the same
construct as pH200 except a CMV driven lacZ gene has been inserted at the
BamHI site. Genes of interest are: EBV oriP, the mammalian origin of
replication, hyg R, the hygromycin resistance gene driven by HSV TK, the
Herpes  simplex virus thymine kinase promotor,  and amp R,  the  ampicillin
resistance   gene.
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Figure 5: The pDR2 cDNA plasmid. A) Map of the pDR2 plasmid containing
oriP,   an origen of replication for mammalian cells. Col El oh, for replication
in E. coli cells, EBNA-1, for stable maintenance of the plasmid as an episome,
hygf for selection in human cells, ampf for selection in bacteria, a cDNA
insert and an RSV-LTR,    the Rous-Sarcoma virus promoter for the
expression of the cDNA in mammalian cells, and B) a restriction digest of
pDR2 plasmid with BamHl  and Xba enzymes, the two restriction sites
flanking the cDNA segment. Lane 1 - plasmid alone, lane 2 - 1-Hindi marker,
lane 3- pDR2 digested with Xba and BamHl, lane 4 - pDR2 digested with
Xba only, lane 5 - pDR2 digested with BamHl only, lane 6 - 1-Hindi marker.
There is a smear of DNA in the lower portion of lane 3, indicating the
presence of cDNA fragments of different sizes.
ps; :rt?^^?i5g*?K-**c»j'S-'"^
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growth phase on the fusion day.
2. Isolation of the microcells.
On the day of the fusion the media from the T-25 flasks containing the
A9 cells was removed and the flasks were filled with pre-warmed
cytochalasin B (100 ug/ml).    After 20-30 minutes at 37^ C, the six flasks
were placed, along with  100 ml of distilled deionized water (ddH20) into
each well of a Sorvall SS-45 rotor and spun at 12,000 rpm's for 1 hour at
25-30° C.    When the flasks were are removed, a white pellet containing the
microcells and cell debris, was apparent at the bottom corners.    Under
sterile conditions, the cytochalasin B was taken out, (and filtered through a
22|i filter to be used again), and 1.5 ml of fresh unsupplemented RPMI
media (UM) was added to each flask.    The pellets in the flask were
resuspended in the media and collected in a 15.0 ml centrifuge tube.    The
media collected  was then  spun down at approximately 2100 rpm's for  10
minutes in an lEC tabletop centrifuge.
After spinning, the  media was aspirated off and the pellet resuspended
in 10 mi's fresh UM.    It was then filtered through 8-|j,m, 5-|j,m and 3-|j,m
polycarbonate filters (Nucleopore, Pleasonton, Ca.) serially and collected in
a centrifuge tube.    This purified microcell pellet suspension was then spun
at 2100 rpm's for  15 minutes.
3. Fusion of the microcells and recipient cells.
At this point the fusion methods can vary depending on if the
recipient cells are monolayer or suspension cells.    Below are four
variations employed: For monolayer recipient cell lines, GM6914A and
GM1309B.
Standard   protocol:
The monolayer recipient cell lines GM6914A or GM1309B were washed
twice with PBS in preparation for the fusion.    After the purified microcells
were pelleted and the media was removed the pellet was then
resuspended in 2.0 mis of PHA (100 ug/ml) and immediately  added to one
of the 2 plates.    2.0 mis of PHA (same concentration) with no microcells
was added to the control plate.    The dishes were then incubated for 5
minutes at RT and 5-15 minutes at 37° C, depending on the toxicity of the
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cell line to the PHA.    After a given time the PHA was taken off and 1.0 ml
of 45 % PEG was added for one minute after which they were washed
three time consecutively with UM.    After the last washing,  10 mis of
complete growth media was added to the cells which were then incubated
at 370 C for at 24 -48 hours.
Modified protocol.
The  same  procedure  was  followed  with  the  exception  that the recipient
cell line GM1309B was grown in 6-well plates and when the PHA-microcell
suspension was added, they were centrifuged in an lEC centrifuge for 5
minutes at  1500 rpm's This variation was employed in an attempt to
improve the chances that the microcells would attach to the cells.
Suspension recipient cells.   Modified protocol #1.
Approximately  1.0 x  10'^    lymphoblastoid cells were placed into each of
two  15.0 ml centrifuge tubes and spun down at  1200 rpm's for five
minutes in a tabletop lEC centrifuge.    After spinning, the media was
removed and the cells were washed once with UM.    After washing, the
media was aspirated from both tubes.    To the first tube, the microcell-PHA
mixture was added and to the second tube, 2.0 mis of PHA with no
microcells was added.    The cells were exposed to PHA for approximately 5
minutes at RT and 10 minutes at 370C.   After this time 2.0 mis of UM was
added to inactivate the PHA and the cells were spun down at 1300 rpm's.
The PHA was taken off and 2.0 mis of 45% PEG was added for one minute,
after which time 10.0 mis of UM was added and the cells spun down at
1500 rpm's.    This washing procedure was repeated  1-2 times.    After the
last time, the cells were resuspended in complete RPMI media with  10%
FBS, placed into a 100 mm dish and incubated at 31^ C.
Modified  lymphoblast protocol #2.
Approximately 2.0 x  10^ lymphoblast cells in the log phase of growth
were placed into a 50 ml centrifuge tube and spun down at 1200 rpm's for
five minutes.    After spinning, the media was removed and the cells were
washed once with UM.    After washing the media was removed and the
cells were resuspended in 6.0 mis of fresh UM.    Three mis of this solution,
approximately  1.0 x  10^ cells, were placed into each of two wells in a 6-
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well plate (Falcon).    The plates were spun down at 1500 rpm's for 10
minutes to obtain a forced monolayer.    At this point the UM was removed
from the cells and 2.0 mis of PHA-microcell suspension was carefully
added to the cells and incubated the appropriate amount of time.    After
the appropriate time, the PHA was removed and 2.0 mis of 45% PEG was
added.    After one minute in PEG, three to four mis of UM was added to the
wells and the cells were dislodged using a Pasteur pipette.    This solution
was then added to a 15 ml centrifuge tube containing 10 ml of UM and
spun down at  1500 rpm's.    This washing procedure was repeated  1-2
times.    On the final time, the cells were resuspended in complete RPMI
media with 10% FBS, placed into a 100 mm dish and incubated at 370 C.
4. Selection of transformed cells.
Two days after the fusion, the cell were placed on selection in G418
(neomycin, [Fisher]) for up to 25 days, changing the media every 5-7 days.
For the GM1309B and GM6914A fibroblasts, 200 and 800 ug/ml of G418
respectively were used.    For the FA-A lymphoblast, 800 ug/ml G418 was
used  though  other concentrations,  of 400,   1000,  and   1200 ug/ml  were
tried as well.
Project Two.
Plasmid   Preparation: All of the plasmids were prepared by the methods
described in Current Protocols for the Cesium Chloride-Ethidium Bromide
preparation of plasmid DNA (5)    with some minor alterations which
include adding a LiCl precipitation step after the first ethanol precipitation,
in order to remove part of the RNA, and placing the DNA through two
rounds of CsCl separation.
The pDR2 plasmid came incorporated into a X phage.   AMI E. coli were
infected  with  approximately   1.0  xlO^ phage particles at which point the
pDR2 insert was detached from the phage by the addition of ITPG which
signals recombination to occur at the sites flanking the pDR2 plasmid.
After this  normal plasmid preparation protocol  was  followed.
Following the second round of CsCl centrifugation, the plasmid band was
removed  and TE  saturated iso-propanol was added to remove the ethidium
bromide.    After this, the solution was dialysed for 2 days in a solution of
IX TE buffer (10 mM Tris, 1 mM EDTA).   The buffer was changed three or
more times during this time.
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Quantifying   plasmid:    To determine the amount of plasmid, 20 ul of the
plasmid solution was diluted into 1000 ul ddH20.   Using a
spectrophotometer, the OD at 260 and 280 nM was then taken.    If the ratio
of OD at 260 over 280 was 1.8 or over, the amount of plasmid could be
determined  by  the  following  formula:
OD at 260 nm   x   dilution factor   x   50 mg/ml     =     ug of plasmid/ml
To determine the purity and the size of the plasmid,  approximately 5.0
ng of plasmid was placed in one lane of a 1% agarose gel and run for 30-45
minutes at 90 volts.    The X,-hindI marker, which has bands of pre¬
determined size,    was run in an adjoining lane.    To correctly determine the
size of the plasmid, the plasmid was cut with restriction enzymes and then
run on the gel to confirm the presence of cDNA fragments in the pDR2
plasmid (figure 5-B).
Transfection   methods:
Electroporation: 5.0 x 10^ cells in log phase growth in 0.3 mis RPMI
1640 media with 10% FBS, was added, along with 20.0 ug plasmid DNA, to
a BioRad 0.4 cm cuvette and placed on ice for 10 minutes. After this time
the cuvette was placed in the BioRad Gene Pulser electroporation chamber
and electroporated at the desired voltage (v) and capacitance (uF). After
electroporation, the cells were placed back on ice for 10 minutes and then
diluted in  10 mis of complete media and incubated at 37^0.
Lipofection:  Method A: For each reaction: 40.0 ul of Lipofectin® and  15.0
ug of plasmid DNA were added, respectively, into each of two 3.0 ml
polystyrene tubes containing 1.5 mis of OPTI-MEM media (Gibco).    The
contents of each tube were then mixed and allowed to incubate for 10
minutes at RT.   It was then, along with 5.0 x 10^ lymphoblastoid cells
previously washed in PBS, added to one well of a 6-well plate (Falcon) and
allowed to incubate at 37^ C for 12-18 hours.    The OPTI-MEM media was
then removed and the cells were resuspended in complete RPMI media
and placed back in the incubator at 37^0
HSC's 72 and 230 were tested with this method to determine the short
and long term transfection efficiency using lipofection.    In one test, these
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two cell  lines  were  transfected  with four different plasmid,  pH200,  pH210,
pH250 and pDR2, all of which contain the gene for hygromycin resistance.
After two days approximately 2.0 x 10^ cells were used for the ONPG assay
and the remainder were placed on 200 ug/ml hygromycin B.
Lipofection:  Method B: For each reaction: Into two separate polystyrene
tubes were placed, respectively, 6.0-12.0 ug of plasmid DNA in OPTI-MEM
media to a volume of 100 ul and 20.0 - 40.0 ul of Lipofectin® with OPTI-
MEM media to a volume of 100 ul.    The contents of each tube were
combined and allowed to incubate at RT for 10 minutes.    After this time
the DNA-liposome suspension was added to the cells, (pre-washed once in
OPTI-MEM media), and resuspended in 800 ul of this same media.    This
solution was incubated for 7-14 hours at 370 q at which time 4.0 mis of
media was added to the cells which were returned to the incubator for 24-
36  hours.
This method was used to test the lipofection transfection efficiency of
the FA-B lymphoblastoid cell line, HSC 230.   Into each of four wells of two
6-well plates were placed 2.5 and 5.0 x 106 jjSC 230 cells, respectively.
Then to the four wells of each plate was added DNA-liposome complexes
incubated, as described above, in ratios (ug DNA to ug Lipofectin®) of 6:12,
6:24,  12:24 and 12:36.    The plates were incubated for 8 hours after which
time 4.0 mis of complete media was added to each well.    48 hours later an
ONPG assay was performed to determine the level of P-galactosidase
expression.
Endocytosis-fection: A detailed description of the preparations of the
materials used for this assay are described in Wagner et al., 1992, and
Gotten et al., 1992 (11, 58).    The material used for this experiment was
prepared and generously supplied by Dr. D. Curiel, (UNC-Ch School of
Medicine).
DNA-Adenovirus   conjugate   preparation: (per reaction) On the day of the
transfection, 0.25 x  lO^o particles  of replication-incompetent  adenovirus
(A249) was aliquoted into a  15.0 ml centrifuge tube.     In a separate tube,
1.25  ug of monoclonal antibody-poly-lysine (MP301pL) was diluted in
125.0 ul of 50 mM HBS (150 mM NaCl/20 mM HEPES, pH 7.3), added to the
adenovirus, and incubated at RT for 30 minutes.    After this time, 6.0 ug of
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plasmid DNA was diluted in  125.0 ul of HBS in a separate tube and added
to the first tube and again incubated at RT for 30 minutes.    Lastly 3.6 ug
transferrin poly-lysine  (hTFpL)  and  2.6  ug poly-L-lysine  295  (pL295)
were placed in 125.0 ul of HBS and again added to the first tube and
allowed to incubate for 30 minutes (see figures 6 and 7).
At this point the DNA-adenovirus complex was added to the cells in 1.0
mis of media containing 2.0% FBS.   After 1-2 hours at 37^ C, media with
FBS was added so that the cell concentration was 5.0 - 7.0 x 10^  cell/ml
and the FBS concentration was 10.0%.    The cells were then incubated for
48 hours after which time they were placed on selection and/or the
appropriate   assays   were   performed.
Test  Experiment  #1: In the first trial, approximately 20 hours pre-
transfection, 6.0 x  10^ cells in 10.0 mis were seeded into each of two 100
mm plates.    To one plate was added 50.0 ug/ml desferrin in order to
induce formation of transferrin receptors on the cell surface.    The other
plate received no desferrin.    The following day, 20% of the cells from each
plate were taken and used for the endocytosis-fection experiment.     (The
remaining cells were used for a parallel transfection using electroporation.)
At the time of transfection, in a 60 mm tissue culture dish (Falcon), 0.5 ml
of  the   DNA-adenovirus-transferrin-poly-lysine  complex   was   delivered   to
1.5 X 106 actively dividing cells in 1.0 ml of media containing 2.0 % FBS,
and allowed to incubate at 37^0 for 1.5 hours.   After this time 1.5 ml of
complete media with 18% FBS was added to each plate which were placed
in a 370 C incubator.    After thirty hours, the cells were counted and an
ONPG assay was performed.
Test  Experiment  #2  : In the second experiment, the standard procedure,
as described above, was used for four different trials, with variations in
the amount of various components.    2.0 ug of the reporter plasmid pH210
was used instead of the 6.0 ug of the CMV-lacZ construct used in Test #1 in
all four trials.    This difference aside, trial 3 was done under the same
conditions as in experiment 1.   In trials 1, 2, and 4, no pL295 was used and
as well, in trial 4, only 1.25 x lO^o particles, 50% of the normal amount, of
adenovirus  was  used.
After the formation of the DNA-adenovirus conjugate, 0.5 mis of it was
added to 4.0 x 10^ HSC 230 cells in 1.0 mis of 2.0 % media.   After 2 hours.
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Figure   4:   Construction   of   Adenovirus-DNA   complex.
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(Replication
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Figure 6: Procedure for preparing the adenoviral-DNA complex. The linker antibody-
polylysine  macromolecuie  is  incubated with the replication-defective adenovirus
providing a site for the plasmid DNA to attach. The transferrin-polylysine (hTFpL)
then binds to the DNA causing it to fold into a "doughnut" shape, (11,12). The
conjugate can then be delivered to the cells.
Figure 7: Mechanisms of the endocytosis-fection
method of transfection.
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1. Adenovirus-plasmid conjugate is added to cells.
^^
^
2. Conjugate binds to adenovirus or transferrin receptors.
3. Bound conjugate is taken up through endocjrtosis.
e3
V
4. Adenovirus disrupts endocytotic membrane, allowing
plasmid to escape.
5. Plasmid migrates to the nucleus.
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4.0 mis of 10% FBS media was added.    48 hours later, the cells in each trial
were counted and 1.0 x 10^ cells from each trial was used for the ONPG
assay.    The remainder of the cells, at a concentration of approximately 4.0
- 5.0 X 105 cell/ml, were placed on 125 ug/ml hygromycin B.    The cells
were counted and the media changed every 4-5 days.     After the tenth day
the dead cells were removed by centrifugation on a ficoll gradient.
Determining   Transfection  Efficiency
In order to determine the most efficient method of transferring  the
plasmid into FA cells, plasmids containing the lacZ gene (which codes for
the enzyme P-galactosidase) were transfected into FA cells.    This enzyme
breaks down  the  substrate  ONPG  (o-nitrophenyl-p-D-galactopyranoside)
forming  a yellow  by-product,  and  subsequently the relative  amount of the
enzyme produced  can  be determined  by measuring the  optical  density
(OD) of the solution; the intensity of yellow being directly proportional to
the amount of P-galactosidase.    Two plasmids were used which contained
the lacZ gene, one of which has the SV40 promoter (pH210) and the other
which has the CMV promoter (pH250), the latter of which has been shown
to be five times as strong as the former (T. Sun, unpublished data).
P-galactosidase or ONPG Assay.
A description of the |3-galactosidase assay is described in detail by Lim
and Chae, 1989 (38).   Briefly, from 1.0 - 2.0 x 10^ cells were washed once
with phosphate buffered saline solution (PBS) and resuspended in 0.5  mis
of Hanks balanced saline solution (HBS).    This cell solution was then added
to a 1.5 ml eppendorf tube containing 0.5 ml of a 2X ONPG solution (7.0
mM  o-nitrophenyl-3-D-galactopyranoside  [ONPG]  and  10% Nonidet-40  [NP-
40] in HBS).    This solution was mixed thoroughly and allowed to incubate
at 370 C for various time points from 1-62 hours.    At any time point, the
solution was spun in an microfuge at 1350 rpm's for 5.0 minutes to pellet
the cells and cell debris.    The optical density (OD) at 420 nm of the
supernatant was then measured in a spectrometer, using a plastic cuvette.
Afterwards   the  cell  solutions  were  retained  and  re-incubated.
To find the portion of the OD reading due to the presence of the
transfected plasmid, the OD reading from cells transfected with a non-lacZ
plasmid or no plasmid (the background level) is subtracted from the OD
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reading of the lacZ-transfected cell line.    This equals the corrected OD
reading.
Corrected OD reading       =    OD at 420 nm of - OD at 420 nm of
lacZ   transfected   cells non-lacZ   transfected   cells
To take into account the different numbers of cells sometimes used for
the ONPG assay, the OD readings were normalized by dividing the OD
reading by the number of cells used for the ONPG assay, to give an
absorbance unit per cell.
Absorbance  unit =    Corrected  OD  for cells transfected  with  lacZ plasmid
per cell,  (AU) # of cells used in ONPG assay
Determining   transfection   percentage:
When the ONPG assay is performed on cells which have been
transfected with a pH210,    it was sometimes performed on a similar
number of cells from a HSC 93p588Z, a normal lymphoblastoid cell line
which carries the lacZ plasmid driven by the same promotor.    After 3
hours, the OD was taken of experimental and control cells and an estimate
of the percentage of cells transfected was calculated as following:
Transfection  = Corrected  OD reading of transfected cells_____       x 100
efficiency,    (%)        Corrected OD reading of cells with lacZ plasmid
SENSITIVITY ANALYSIS OF SELECTING AGENTS
Hygromycin   sensitivity:
HSC 230 cells were exposed to varying doses of hygromycin B to test
their sensitivity.    In the first trial, 5.0 x 10^ cells/ml in  10.0 mis were
added to each of six 100 mm dishes. 0, 50, 100, 150, 200 and 300 ug/ml
hygromycin B were added to each of the dishes and the cell counts were
taken every two days.    After 6 days the growth percentage was calculated.
In the second trial, 0, 50,  100,  150 and 200 ug/ml hygromycin B,
respectively, were added to each of two wells of a six well plate, each
containing 6.0 x 10^ cells in 3.0 mis.   Cells were incubated six days at 370C
and then counted to determine the percent cell growth.
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MMC   sensitivity:
For each cell line, 1.0 x 10^ cells in 1.0 ml were placed into each well of
a 24-well plate.    Each of the 6 columns of the plate were treated with a
different concentration of MMC including 500, 100, 50, 10, 1, and 0 nM.
The cells were incubated at 37° C for 5 days after which time the number
of cell in each well was calculated and the percent cell growth was
determined. This was performed on FA cell lines HSC's 230, 72, 62 and
normal cell lines UC and HSC 93.
PUVA - Psoralen and UVA light.
2,0 X 105  cells/ml in 1.0 ml were placed into each well of a 24 well
plate.    Each of the 6 columns were treated with a different concentration of
the psoralen derivative, HMT, from 0.1, 0.05, 0.001, 0.005, 0.001  and 0.00
ug/ml.    After the HMT was added, the cells were incubated in the dark at
37° C for 10 minutes and then placed under 360 nm UVA light for 5
minutes.    After this time the plates were placed back in the 37^ incubator
for five days at which point the number of cell in each well was
determined  and the percent cell growth was calculated.
The percent cell growth was determined by the following formula for
treatment of any given cell line with an growth inhibiting agent:
% growth   = (Original cell #     -     Dav   X  cell   number")   concentration   Y
(Original cell #   -      Day  X  cell  number)  no  treatment
Where X is # of days after the treatment with chemical and Y is the
concentration of that chemical administered to the cells
The Selection process:
Cells transfected with a plasmid containing the hygromycin resistant
gene were selected in hygromycin at a concentration that inhibited growth
90-99% after 5-6 days.    Cells were placed in the desired concentration of
the selecting agent and every 4-5 days a cell viability assay was
performed to determine the number of live and dead cells.    After this the
cells were either centrifuged and resuspended in fresh media with
hygromycin or they were placed on a ficoll cushion (Accurate Chemical Co.)
to remove the dead cell and then resuspended in fresh media with
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hygromycin.     Hygromycin-resistant colonies were  seen  after 3-4  weeks  of
selection.
Removing Dead  Cells: The old media on the cells to be placed on ficoll was
removed and the cells resuspended in 3.0 - 5.0 mis of fresh media.    This
suspension was then carefully placed on top of 3.0 mis of Lymphoprep®
(Accurate Chemical Co.), a ficoll gradient, and spun for 10 minutes at 1250
rpm's and  10 minutes at 2000 rpm's.    Live cells collect at the media-ficoll
interface and dead cells pellet to the bottom.    The live cells are then
collected and washed once in 10 mis media to remove the ficoll.    After
washing, the cells are resuspended in  10.0 mis complete media along with
the selecting agent and placed back in the incubator.
Cell  Viability  Assay: The number of living and dead cells in a culture was
determined by treating a small volume of the cells with Trypan blue.
Briefly,  100 ul of Trypan blue was added to the same volume of cell
suspension, for a 1:1 dilution.    Approximately 25.0 ul of this solution was
added to a hemocytometer and the cells counted.    The dead cell are stained
blue while the living cells remain bright.
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Chapter IV: RESULTS AND DISCUSSION
Experimental   results-Project  One:
At least  10 MMCT trials were attempted during an eight month period
with no successful insertion of the HC 20.    It was tried primarily on the
FA-A lymphoblasts though it was also attempted on two FA-A fibroblast
cell lines.
Table 1 shows an overview of the conditions used for most of the MMCT
experiments.    In one of the trials (#3) performed on GM6914A, neomycin
resistant colonies were obtained, but this, upon later macroscopic and
cytologic examination, appeared to be the result of a whole, not a micro-
cell fusion.    After two weeks, the cells began to take on the appearance of
the original A9 mouse cell line and cytologic examination revealed that the
mitotic  spreads consisted mostly of mouse chromosomes.    This result was
most likely the result of a leak in the filter which allowed whole nuclei and
cells  through.
In two of the first trials, HSC 72 was used as the recipient cell line.    The
colcemid concentration used on the A9 cells was 0.002 ug/ml, a value one
to two orders of magnitude lower than the normal values used in the
literature.    A microcell pellet was observed after the microcell purification
in some of these trials, though it is likely that microcell concentration was
small.    The cells in the first trial were spun down in a 6 well plate to force
a monolayer while the other was carried out in a centrifuge tube.    The cells
were placed under selection with 800 ug/ml of G418  and two-three weeks
later they all had died.    Since some microcell pellet was seen after the
purification  step in experiment  1, the colcemid concentration  was not
suspected as a problem.    In the second experiment, the number of A9 cells
treated with colcemid was doubled and the exposure to PHA was lessened.
Though the experiment was not successful, the length of time the cells
survived in G418 was an indication that the concentration was not too
high.    A primary reason for the failure of the experiment may be the low
concentration of colcemid used to form the microcells though there are also
en
Table 1: Overview of IMMCT experiments.
Exp. # Cell line
Cell
Type
Colcemid
(ug/mi) Method
G418
(ug/ml)
Resistant
colonies? Results:
1 HSC72 lymphoblast 0.002 forced monolayer 800 no cells were dead after 2-3 weeks.                            1
2 HSC72 lymphoblast 0.002 cent, tube 800 no cells were dead after 10-14 days.                         1
3 GM6914A fibroblast 0.002 standard 800 yes false positive: leak in  filter.                                    1
4 HSC99 lymphoblast 0.002 centrifuge tube 800 no cells were dead after 10-14 days.                          1
5 GM1309 fibroblast 0.05-0.2 standard 1000 no cells looked sick after treatment.                           1
6 HSC99 lymphoblast 0.05-0.2 forced monolayer 800 no cells were dead after 10-14 days.                          1
7 GM1309 fibroblast 0.05 spin cells 200 no cells looked sick after the treatment: died 4-5 days I
The MMCT procedure is described in the Mterials and Methods. The reactions involving lymphoblast cells were carried out a.) in a six well
plate where they were forced via centrifugation into a monolayer, or b) in a centrifuge tube. Cells were placed on G418 1-2 days after
the experiment.
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indications that the problem may lie with the nature of the cell line and
cell type.
At a later time, a fusion experiment was carried out on another FA-A
lymphoblastoid cell line, HSC 99.    In this trial, the A9 cells were treated
with a colcemid concentration of 0.05 ug/ml and as a result, a more
noticeable microcell pellet was observed.    The recipient cells were forced
to a monolayer in a 6 well plate though when the microcell-PHA solution
was added, the cells lifted up.    After a 17 minute incubation in PHA, the
cells were transferred to a centrifuge tube and spun down.    After the PHA
was taken off and the PEG added, the cells were diluted in UM and washed
two consecutive times with UM and then placed in fresh media.    They
were placed on 800 ug/ml G418 two days later and typically,  10-14 days
later, no live cells remained in either the control or experimental plate.
Two experiments were done on the primary fibroblast GM1309B.    In
both experiments, the colcemid concentration used to treat the A9 cells
was 0.05-0.2 ug/ml and noticeable purified microcell pellets were seen.    In
the first experiment, over one-third of the cells lifted off after the PEG
treatment, indicating that the treatment with PHA and PEG was toxic to the
cells.    Two days later the cells were split and placed on  1000 ug/ml
concentration along with the PHA and PEG treatment, proved to toxic for
the cells.    No live cells were seen after 1-2 days.    In the other experiment,
the cells were spun in a centrifuge after the addition of the microcell and
PHA.    This was done to increase the chances the number of microcells that
attached to the fibroblasts.    Though the PHA and PEG times were lowered,
the spin in the centrifuge as well as the PHA and PEG treatments once
again damaged the cells and very few live cells remained 4-5 days after
the experiment even thought the selecting concentration of G418  was
lowered  to  200  ug/ml.
Discussion
The FA-A lymphoblasts, represented by HSC's 72 and 99, were the cell
line of choice for the majority of the MMCT experiments for a number of
reasons.    First, by nature of their cell type, lymphoblastoid cells can be
grown in large numbers in relatively small volumes compared to fibroblast
cell lines.    This means a greater number of cells can be transfected for a
given volume of media.    A second reason is that these cell lines are
-aBf^^g^«^^*:;!tt#SWSB*SSWS
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immortalized  and  they have  a normal complement (2n=46)  of
chromosomes, unlike either of the fibroblast cell lines.    GM6914A cells are
immortal   but   have   a  rearranged   karyotype   and   an   average  chromosome
number of greater than  seventy which  is  a major reason  why  more
attempts were not made with them.    GM1309B cells have a normal
karyotype but they are not immortal.    It was important to have an
immortalized cell line because these generally grow faster and  are more
receptive to the uptake of foreign DNA than primary or unimmortalized
cell lines (27).  Primary cells lines have a finite life span of undetermined
length so may be unsuitable for an experiment which could potentially
take  many  months  to complete.
Also, a normal complement of chromosomes was deemed an important
characteristic because of the ease and accuracy with which chromosome
breaks can be counted and the location of the breaks identified.    In a
rearranged karyotype with a large number of chromosomes,  such  as  occurs
in GM6914A, all but chromatid breaks can be easily identified, with most
double   strand  breaks   and  translocations  being  indistinguishable  from  the
background chromosomes.    In light of the fact that chromosome breaks can
be easily induced in FA cells, and whose correction could easily be tested,
the desire to count and identify spontaneous break points appears to be a
secondary   concern.
There are many disadvantages to using lymphoblastoid cells, most of
which came to light after work with the subsequent project.    One
disadvantage is that modifications had to be made in the MMCT protocol to
accommodate the use of suspension cells over monolayers.    One of these is
that when solutions such as media, PHA and PEG were to be removed from
the cells, the cells had to be spun down to a pellet before the solutions
could be taken off.    This made it difficult, especially with PEG exposure, to
expose the cells to an agent for a specific, short period of time because the
exposure always included time in the centrifuge, even if the agent was
diluted.    This also contributed to a loss of cells which invariably occurred
with each spin.
Additionally, it has come to light through the work in the second project
that lymphoblastoid cells, especially FA lymphoblasts, are, in general,
harder to transfect and select for resistance cells than are fibroblasts
(personal observations).    In transfection experiments on HSC 72,
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efficiencies of no more than  1-5% have been gained using 5.0 -  15.0 ug's
(2.0 - 7.0 X 1011 particles) of plasmid DNA (54).    In MMCT tests performed
on various human cell lines, no more than 35.0% of cells treated with
colcemid formed microcells with the  average being near  15.0%  (45).   If the
same holds true for A9 cells, then up to 1.0 x 10'^ out of the  approximate
2.0 - 3.0 X 107 cells produce microcells with only a portion of these
actually attaching to the cells and an even smaller portion being taken up.
With this in mind, it is unlikely that a successful microcell fusion could be
obtained with the FA lymphoblasts.    This could be one reason why trial #5
using HSC 99 was unsuccessful.    In this experiment, the appropriate
amount of colcemid was used, a microcell pellet was observed after the
purification step, the PHA and PEG toxicity was not a factor and the cells
were selected on 800 ug/ml G418, dying off 10-14 days later.
In addition to having a low efficiency of transfection, the process of
selection is more difficult using lymphoblasts  (especially FA lymphoblasts)
than fibroblast, once again based on observations made in the second
project.    Whereas in theory, one fibroblast cell is capable of propagating
into a colony, lymphoblast cells must be at a certain threshold cell density
before they will multiply to any degree (personal observation).    Therefor a
much higher percentage of lymphoblast than fibroblasts would have to be
transfected in order for resistant colonies to appear.    Also, once a
fibroblast cell has died, it will lift off the plate, making it easy to
distinguish and separate the live from the dead cells.    With lymphoblast
cells, the dead cells remain in the media with the live cells so it is more
difficult to differentiate the two.    The accumulation of dead cells is also
thought to have a negative impact on the growth of the live cells.    Therefor
in this experiment, even if some cells did take up the neo^ tagged HC 20, it
is questionable if they would be able to grow-up into large enough
numbers to be detected.    In light of these factors it would have been wise
to focus  greater attention on the FA-A fibroblasts.
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CHAPTER V: CONCLUSIONS AND RECOMMENDATIONS
The  microcell-mediated  chromosome  transfer  is  a  common  procedure
used  widely  to transfer human chromosome into either human  or rodent
backgrounds.    It has been used to establish a library of single human
chromosomes in rodent cells backgrounds as well as to transfer individual
human chromosomes to test for the complementation and correction  of
various genes (48, 59).    In the field of DNA repair disorders, the presence
of the Ataxia telangiectasia group D (AT-D) gene was confirmed to be on
HC 11 by the successful insertion of a HC 11 into AT-D cells by way of
MMCT (33).   However, when the same procedure, using HC 20, was
attempted on the Fanconi's anemia group A (FA-A) cells, a successful
insertion of HC 20 could not be achieved.    There are a few reasons which
might account for this.    For the FA-A lymphoblast cells, the problem most
likely involves the nature of the cell line and cell type as described above.
For the FA-A fibroblasts, this failure is due to a poorly planned and
executed experiments.    The GM1309B cells proved more sensitive to the
procedure and selecting agent than had been anticipated.     Only one trial
was done on the immortalized fibroblast GM6914A cells which resulted in
a whole cell fusion.    In light of what is known now, concerning the nature
of fibroblasts  and lymphoblasts,  more  attention  should have  been focused
on this latter cell line.    It must be noted though that, concurrent to the
time this research was being conducted. Dr. Margaret Zdzienicka of the
State University of Leiden, The Netherlands, was also conducting similar
MMCT experiments using the GM6914A cell line.    In five separate trials
she was also unable to successfully transfer HC 20 into this cell line, (Dr. M.
Zdzienicka, personal communication).    This fact underscores the difficulty
of the introduction of foreign DNA into FA-A cells.
Improvement  that could  have  been  made.
There are a couple of improvements that if made, might have
improved the chances for success.    The first of which is to have done a
detailed sensitivity analysis on the FA cell lines, especially the fibroblasts.
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to the agents neomycin, PHA and PEG.    This would have maximized the
chances of achieving a successful selection by insuring that the cells would
not be exposed to chemical concentrations which were too toxic for the
cells to handle.     Another improvement would have been to perform a
MMCT on a normal cell line or a cell line in which a successful MMCT had
been previously been performed.     A positive transfer of a human
chromosome into a normal cell line and not in an FA cell line using the
same method would support the notion that failure in the FA cell line was
due to the nature of the cell and not the procedure.
Recommendation  for  future  research.
The quest to find all four of the FA genes is moving along at a rapid
pace with a number of groups working on cloning each of the groups, with
FA-group C having already been cloned.    Therefor, it may be of little worth
spending more time trying to locate the chromosomal location of the FA-A
gene when its precise genetic location as well as gene code may be close to
being discovered.    If research were to be taken up again on this project, it
would best to advisable to find an immortalized FA-A fibroblast cell line.
Recently, the classification of GM1309B and hence the GM6914A cell line
as belonging FA group A has been called into question by the discovery of
a mutation in this cell line at the FA-C gene locus (61).    However, the
authors  remain doubtful that this represents a true FA-C mutation.
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CHAPTER VI: RESULTS AND DISCUSSION-PROJECT TWO
FA-A   and  FA-B   lymphoblasts  were  transfected  with  plasmids  which
contain the lacZ gene in order to determine the efficiency of transfection.
Two days post-transfection they were placed in an ONPG solution and the
OD was subsequently measured.    To normalize the results between
experiments, the OD was divided by the number of cells used for the assay
to give an absorbance unit per cell or AU.    They were also transfected with
the cDNA library to see if stable maintenance of the plasmid could be
obtained.    The most common AU values obtained were in the range of 0.15
-1.0 (x 10-7) for the  SV40-driven plasmid though higher values were
obtained with endocytosis-fection.    These values, based on the second of
the   endocytosis-fection  experiments   roughly   correspond   to  transfection
efficiencies of 1.0-5.0%.    In a FA-A lymphoblasts the cDNA-containing
plasmid was able to be stably maintained with an AU, after correcting for
plasmid strength, of only 0.15.    (Since the CMV-lacZ is approximately five
times stronger than the SV40-lacZ then values obtained with the former
plasmid are divided by five to give a normalized result).    However, for the
FA-B  lymphoblasts values two-three times higher than this failed to yield
resistant colonies.    The threshold value which will result in stable
maintenance  of the library is unknown.
Results  of Transfections-Method I:  Electroporation
Transient   assays
The major factors influencing the outcome of transfection using electro¬
poration are voltage and capacitance.    Other important factors are cell
volume, cell density, plasmid amount, cuvette size,  and temperature.
Numerous electroporation experiments were done on HSC 230 to deter¬
mine the transfection level, all of which yielded relatively poor results.
In the initial experiment, D/R Raji cells, HSC  1199-ll-2(monolayers),
and HSC 230 (suspension) were electroporated with the pH210 plasmid
under  three  different  voltage  (v)/capacitance  (uF) conditions;  200v/ 960
uF,  150v/ 960 uF, and 200v/ 500 uF.    All other factors were kept constant.
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Table 2: Relative lacZ expression in FA-B cells transfected via electroporation
A) Original OD readings at 420 nm.
ELECTROPORATION CONDTTIONS
Cell line 200/960t 150/960 200/500
D/R Raji 0.126 0.765 0.785
HSC230 0.118 0.454 0.369
HSC1199-11-2 0.027 0.078 0.050
B) Estimated AU X 10A-7)
ELECTROPORATION CONDmONS
Cell line 200/960t 150/960 200/500
D/R Raji 0.190 0.665 0.761
HSC230 0.170 0.354 0.299
HSC1199-11-2 0.018 0.076 0.018
All cells were transfected with the pH210 plasmid using standard electroporation protocol
while varying the voltage and capacitance. Table 1A contains the original OD readings taken
after 24 hours incubation in ONPG. Table IB contains the estimated relative lacZ expression
obtained by first subtracting the estimated background signal from the original OD readings
then dividing this number by the estimated cell number used for the ONPG assay. The back¬
ground signals and specific cell numbers were not taken and so estimates, based on sub¬
sequent electroporation experiments, were used. The numbers in 1B represent OD units per
cell. D/R Raji is a hybrid cell line grown in a monolayer which had been successfully
transfected via electroporation (52). HSC's 230 and 1199-11-2 are transformed lymphoblast
and fibroblasts respectively, belonging to FA group B.
t = voltage (v)/ capacitance (uF)
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including a cell density of 5.0 x 10^ in a volume of 0.3 mis using 20.0 ug
pH210 plasmid, in a 0.4 cm cuvette at O.O^C.   All of the cells were used for
the ONPG assay 2 days after the transfection and the OD reading taken
after 24 hours (table 2).    The initial ONPG results seemed promising, with
the solution of cells in ONPG turning noticeably yellow for some of the
conditions.    These corresponded to OD readings of almost 0.50 for the HSC
230 cells and over 0.75 for the D/R Raji cells.    However taken in light of
the high number of cell most probably used for the ONPG assay, the
readings weren't as high as they appeared.     Since the cell numbers were
not counted, accurate AU value's could not be obtained especially for the
first condition which had the highest voltage and the highest rate of cell
death.     However, for the latter two conditions, fairly accurate estimates
could be made of the cell numbers based on subsequent electroporation
experiments.
The results indicate that of the conditions used, the  150/960 and
200/500 voltage to capacitance conditions were  similar in effect and were
superior to the 200v/960 uF condition.    However, as indicated, there is
uncertainty as to the level of expression of the latter condition.
These results also suggest that FA-B  lymphoblasts can be electroporated
at a two-fold higher efficiency than the FA-B fibroblasts.    The signals for
the fibroblast were lower than the FA-B lymphoblast in all three
conditions barely reaching above the background.    They appear also to
have an order of magnitude lower efficiency of transfection than the D/R
Raji cells.    Indeed the FA-B fibroblast grows at a slower rate and appear to
be more sensitive to such factors as media pH than is either D/R Raji cells
or HSC 230 (personal observation).    Thus they may also have been more
sensitive to the effects of electroporation.
Even with the error involved, the highest relative signals (AU's) were
well below 1.0 x 10-7 for the FA-B cells and were slightly under 1.0 x 10-7
for the D/R Raji cells, indicating a low efficiency of transfection.
In a later experiment, lymphoblasts from three FA cell lines, HSC's 72,
(FA-A), 230 (FA-B), and 62 (FA-D) were electroporated with the pH250
plasmid using standard conditions including  150v and 960 uF, conditions
determined in the first experiment to be the most efficient (table 3, figure
8).    The FA-B lymphoblast had a level of transfection between that of the
FA-A and FA-D lymphoblasts.    The estimated AU for HSC 230 was 0.8 x
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Table 3: LacZ gene expression in FA lymphoblasts transfected by eiectroporation
Cell
Line
Corrected
OD (420 nm)
Est. cell #
used in assay
Est.
AU *
HSC72 0.27 19.50 1.40
HSC 230 0.15 17.40 0.87
HSC62 0.01 14.00 0.06
HSC's 72, 230 and 62 representing FA groups A, B, and D respectively were electroporatedunder standard conditions of 150 volts, 960 uF capacitance with 5 x 10'^6 cells, usingthe pH250 plasmid. The ONPG assay was performed 48 hours later. The corrected OD = OD(lacZ transfected cells) - OD (non-lacZ transfected cells). All cell numbers expressed inunits X lO'^S and are estimated based on subsequent experiments.* = absorbance unit per cell x 10^^-7.
LacZ EXPRESSION IN 3 FA LYMPHOBLASTS TRANSFECTED
VIA ELECTROPORATION.
<
o
HSC 72 HSC 230 HSC 62
cell   line
Figure 8: Relative expression of the lacZ reporter gene in threeFA cell lines transfected with plasmid pH250 by eiectroporation.HSC 72, 230 and 62 belong to FA groups A, B, and D respectively.
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10-7, (+/. 0.22 X 10-7) a result comparable, for the SV40-driven lacZ
plasmid, to the earlier experiment.    Overall, electroporation did not prove
to be an efficient way to transfect either the FA-B fibroblast or
lymphoblast.
Stable   transformation   using   electroporation
Based on the results of the first experiment, where the OD readings
seemed high and the FA-B cells transfected at two-thirds of level of the
control reading,  a large scale transfection of the library was attempted
using electroporation.     1.0 x  10^  cells were electroporated in  10 different
trials in 0.4 ml media.    The cells were selected at 200 ug/ml hygromycin B.
After three weeks it was apparent that no hygromycin B resistant cells
were  being  selected.
Method II: Lipofection
Transient   assays.
The level of lacZ expression in cells transfected with a lacZ reporter
plasmids  via lipofection were  slightly higher than  ones for electroporation.
Two principle lipofection experiments were carried out looking at the
effect of cell number as well as the plasmid and liposome amounts.
In the first of these experiments, HSC 72 and HSC 230 cells were
lipofected (using Method A) with four different plasmids, each of which
contained  the  hygr gene.   HSC 72, an FA-A cell line, was used as a
comparison cell line to FA-B to see if the various EBV based plasmids could
be successfully maintained in these cells.    The ONPG assay was performed
two days post-transfection and OD readings were taken 24 hours later.
The readings for HSC 230 were similar to the background signal and are
not shown.   The results from HSC 72 are seen in table 4 and figure 9.    The
expression of the pH250 plasmid was three to four times above the
background signals (those of pDR2, pH200 and cells with no plasmid), a
poor result given the strength of the lacZ promoter.    The expression of the
pH210 was indistinguishable from the background signals because of the
low transfection efficiency (based on the results from pH250)  and because
the concentration of the pH210 used was 2.0 instead of 6.0 ug.
In the second of these experiments, two of the variables mentioned
earlier, amount of plasmid and liposomes, were varied to determine the
optimal lipofection conditions (using method B) on FA-B lymphoblasts.
LP-72bg
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Table 4: LacZ gene expression in FA-A lymphoblasts transfected using lipofection.
trial
Plasmid lipofctn
amt (ug)
Measured
OD
Corrected
OD
AU
(10-^-7)
hyg.
resist?type amt (ug)
1 pH210 5 40 0.057 0.007 0.04 no
2 pH250 15 40 0.163 0.112 0.75 no
3 pH200 15 40 0.051 — — no
4 pDR2 15 40 0.040 — — yes
5 - 0 40 0.027 -- -- no
HSC 72 (FA-A) cells were transfected via lipofection with two reporter (pH210 and
pH250) and two non-reporter (pH200 and pDR2) plasmids all containing the hygR gene.
The ONPG assay was performed 48 hours post-transfection and the OD reading taken 24
hour after that. Subsequent quantitation of pH210 revealed the concentration to be 1/3 of
ohginal measurement. The corrected OD = OD (cell trf. with lacZ plasmid) - OD (cells trf.
with pH200). Two days post-transfection the cells were also placed on hygromycin B (200
ug/ml) and selected for three weeks after which time, only cells transfected with the pDR2
plamsid yeilded resistant colonies.
LacZ GENE EXPRESSION IN FA-A LYMPHOBLASTS TRANSFECTED
VIA LIPOFECTION.
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Figure 9: HSC 72 cells were lipofected with 2 ug of pH210 and 6 ug each of pH250,pH200 and pDR2 and no plasmid (0), and the lacZ expression measured 2 days later.The former two plasmids carry the lacZ gene while the latter two do not.
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Table 5: LacZ gene expression In FA-B lymphoblasts transfected by lipofection.
cell
number
pIsmd
(uq)
lipfcn
(ug)
CORRECTED
OD         AU*
2.50E+06 6 12 0.020 0.10
2.50E+06 6 24 0.048 0.24
2.50E+06 12 24 0.045 0.23
2.50E+06 12 36 0.204 1.02
cell
number
pIsmd lipfcn
("9)
CORRECTED
CD         AU*
5.00E+06 6 12 0.154 0.77
5.00E+06 6 24 0.083 0.42
5.00E+06 12 24 0.148 0.74
5.00E+06 12 36 0.007 0.04
HSC 230 (FA-B) cells were transfected with a lacZ reporter plasmid (pH210) by lipofection using two
different cell concentrations. The amount of plasmid was varied as was the amount of liposome. The ONPG
assay was performed 48 hours post-transfection using 2 x 10'^6 cells and the OD readings taken 24 hours
later. The corrected OD = OD (lacZ transfected cells) - OD (cells only).
* = absorbance units per cell x 10'^-7
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LacZ EXPRESSION  IN  FA-B  LYMPHOBLASTS TRANSFECTED
VIA LIPOFECTION.
<
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ͣ 6/12
S 6/24
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start,  cell   #
Figure 10: Two different concentrations of HSC 230 cells were lipofected with
various plasmid (ug pH210) to liposome (ug lipofectin) amounts.   The lacZ
expression was measured 2 days post-transfection and given as AU per cell.
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The results are shown in table 5  and figure  10.    No clear pattern emerged
as to the ideal conditions.    For the four trials which started with 2.5 x 10^
cells, the relative expression of the first three is below 0.25 x lO'^AU's per
cell, while the fourth condition, which used 12.0 ug of pH210 with 36.0 ug
of liposome had relative expression of over 1.00 x lO-^.   For trials which
started with 5.0 x 10^  cells, a different pattern emerged  with the first
three conditions having the highest levels of expression, (AU's of over 0.70
X  10-7 for conditions #1 and #3 and 0.42 x 10-7 for condition #2) and the
last one having little or no expression.    (This low reading for the last
condition is most likely due to an error in preparation).    One reason for the
disparity in the results may be that the cells in the latter trial (those
starting with 5.0 x 10*5cells)  were incubated for two days post-transfection
at a cell density too high to allow for the cells to double (1.0 x 10^  cell/ml).
This may have had an adverse effect on the expression of the plasmid.
Though no clear pattern was seen which would indicate the best
conditions, results were obtained with this method that were at least twice
the order of magnitude as those obtained with transfection by
electroporation
Stable  transformation  using  lipofection.
The HSC 72 and HSC 230 cells that were lipofected in the first
experiment were place on hygromycin B (200 ug/ml) 2 days post-
transfection to select for hygromycin resistant colonies.    After three to four
weeks only HSC 72 cells transfected with the pDR2 library showed
resistance to hygromycin.    This is significant for two reasons.    One is that
the  hygromycin resistance cells  in  the FA-A  lymphoblasts  were  obtained
despite a rather low level of transfection based on the lacZ gene
expression, (AU/cell = 0.75 with CMV lacZ, comparable to 0.15 for SV40-
lacZ).    The same or greater results were obtained in various trials on the
FA-B lymphoblast using the same plasmid yet no resistant cell could be
obtained.    The second is that, out of the four plasmids transfected, only the
pDR2 plasmid yielded resistant cells.    The reason for this may be that it is
driven by a Rous-Sarcoma virus (RSV) promoter, which is known to be
stronger than the Simian virus (SV40) promoter found in the other three
plasmids.    It also contains a promotor-less EBNA-1 gene which, if
expressed, may enable it to be maintained as an episome, thus preventing
its being cut (potentially at the hyg^ gene site) and integrated into the
5 1
genome,  thus  decreasing the number of cells  expressing the hygromycin
resistance gene.    HSC's 72 and 230 were both transformed with EBV
containing  the EBNA-1   gene  and thus  should  already express  this protein.
However it may be that the additional expression of EBNA-1  provided by
the pDR2 plasmid may confer an advantage to these cells over cells
transfected with the other plasmids.    There is indeed evidence that the
EBNA-1 gene of pDR2 is expressed.    When plasmid DNA was extracted
from an SV40-immortalized cell line carrying the pDR2 plasmid and used
to transfect bacteria, plaques were formed after 24 hours  in  the presence
of ampicillin.    This would indicate that the DNA collected from these cells
was pDR2, since it is the only known virus in these cells which confers
resistance to ampicillin, and hence, that pDR2 was maintained as an
episome which it will do only in the presence of EBNA-1 (personal
observations).
Another transfection of pDR2 plasmid into HSC 230 cells by lipofection
using method B was initiated and the cells selected at 100 ug/ml two days
post-transfection.     As with the previous experiment, no resistant cells
were   obtained.
Method  III:   Endocytosis-fection
Two experimental tests have been performed with HSC 230 cells using
the endocytosis-fection method, both with markedly higher (4X) levels of
transient lacZ expression  than either lipofection  or electroporation  (figure
16).    The crucial variables in endocytosis are the cell number, and the
amount  of adenovirus,  antibody  poly-lysine,  transferrin  poly-lysine,  poly-
lysine, and plasmid, as well as the order in which they are incubated (See
figures 5 and 6).    An additional factor which was tested in the first
experiment was  the induction of transferrin receptors  on the cell  surface
by the exposure of the cells to desferrin.
Transient Results - Endocytosis-fection - Test #1:
In the initial test of the endocytotic-fection method all of the variables
were kept constant with the exception that one group of cells was exposed
to the drug desferrin, while the other group was not. Concurrent with the
experiment on FA cells, a fellow lab partner. Dr. Suming Wang, also carried
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out  the  same  experiment on  Xeroderma Pigmentosum  variant  (XP-V)  cells
(50).
Effect of desferrin on cell survival.
It appears  that the treatment of the cells with desferrin was extremely
toxic to the cells.    On the day before the transfection, both the treated and
untreated plates contained 6.0 x  106 HSC 230 cells.   The next day, 20% of
the cells from each plate were used for the endocytosis-fection  experiment
and the remaining cells used for a electroporation experiment.     Thirty
hours post transfection, of the cells originally incubated with desferrin, only
16.7 x 105 cells remained while over 113.0 x 10^ cells remained for the
unexposed cells, over a six-fold difference in number (table 6).
Effect of transfection method on cell survival.
In  addition,  it appears that the endocytosis-fection  treatment by itself
was more deleterious to the cells than the electroporation treatment.    At
the time of transfection, there were four times more cells used for the
latter experiment than for the former while after 30 hours the difference
was 7.5 times (table 6).
Effect of Desferrin on transient transfection efficiency:
The OD reading of the HSC 230 cells treated with desferrin was similar
to the background level, due in part to the low number of cells which
survived to be tested.    Therefor the effect of desferrin on the efficiency of
transfection for HSC 230 cells could not be determined.    However, the XP-V
cells treated with desferrin had a lacZ level of expression 50% that of the
untreated cells, (15.0 x  10-7 compared to 30.0 x 10-7 absorbance   units  per
cell,  [Wang,  1992, unpublished]).
Efficiency  of transfection  using  endocytosis-fection.
For the cells which were not exposed to desferrin, the level of lacZ
expression was higher than with any previous transfections on HSC 230
cells using either electroporation or lipofection.    The level of lacZ
expression in the FA-B lymphoblasts using this method was 7.6 x  lO-^ AU's
per cell, (OD reading of 0.34 for 4.5 x 105 cells), while for the XP-V
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Table 6: Effect of desferrin on FA-B lymphoblasts.
Condition-> desf - desf *
live cell numbers TOTALS live cell numbers        TOTALS
DAY -1 60 60
DAY  0 Endo. Elec. Endo. Elec.
20% 80% 100% 20% 80% 100%
DAY +1 13.40 100.00 113.40 4.20 12.50 16.70
All numbers equal number of HSC 230 cells x 10'^5.
On the day before the transfection experiment, approximately 60 x IC'S cells were seeded into
each of two plates, one containing 50nM desferrin (desf +). On day 0, all of the cells in each plate
were split and used for either endocytosis-fection (Endo.) or electroporation (Elec). On day 1 the
cells were counted. The number of cells treated with desferrin that survived until day 1 was 15%that of the number of untreated cells.
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7: LacZ gene expression in FA-B lymphoblasts tranfected via endocytosis-fection.
condition
OD at 420 nm corrtd
OD
Call #
for ONPG
AU
(10^-7)original bkgrd ievelf
desf -H 0.062 0.035 NAB 1.40E+05 - -
desf - 0.382 0.040 0.342 4.50E+05 7.60
HSC 230 cells, some incubated in the presense of 50 nM desferrin (desf +) 20 hours pre-transfection
were Iransfected with the lacZ containing plamsid. pH250. An ONPG assay was initiated 30 hours
post-transfection with 1.0 ml of cell suspension and maximum optical density (OD) readings were
obtained 62 hours later.
t = estimated background level of lacZ expression based on previous experiments.
NAB - Not above background
RELATIVE LacZ EXPRESSION IN FA AND XP
LYMPHOBLASTS  USING  ENDOCYTOSIS-FECTION: TEST #1
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Figure 11: Relative transfection levels of lymphoblasts from Xeroderma
Pigmentosum (XP) and Fanconi's Anemia (FA) using endocytosis-fection.
Cells in the "desf +" condition were incubated in 50 nM desferrin 20 hours
prior to the experiment.
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lymphoblasts it was over 30.0 x  10-7, (OD reading of 2.2 for 7.5 x 10^ cells,
[table 7, figure 11]).
Endocytosis-fection - Test #2:
A second test using endocytosis-fection was carried out on the FA-B
lymphoblast cell line using the pH210 reporter plasmid.    Based on findings
by Dr. S. Wang that the poly-lysine 295 (PL295) exerted a toxic effect on
the cells, it was omitted in some of the trials of this experiment.    The
amount of adenovirus was also reduced in one of the trials to test whether
use of a lower amount might possibly improve the chances for long-term
selection.     By reducing the adenovirus amount, a threshold concentration
may be discovered which can be tolerated by the cells thus allowing stable
maintainance of the plasmid.    To this same effect, cells in trial #2 were not
placed on hygromycin until four days post-transfection instead of two,
thus allowing the cells time to recover from the effect of the endocytosis.
HSC 230 cells in trial #3 of this experiment were transfected under the
same conditions as the cells in Test #1 with the exception of the plasmid
type (pH210 instead of a CMV driven lacZ construct provided by Dr. D.
Curiel), and the plasmid amount (2.0 ug instead of 6.0).    The maximum
reading for this condition, taken 48 hours after transfection, was 3.7 x  10-7
AU's percell, (OD = 0.75 for 2 x 10^ cells).   This result was over 20% the
maximum level of lacZ expression given by the cells line HSC93p588Z, a
normal lymphoblast which carries the pH210 plasmid (table 8, figure  12).
Taking into account the differences in promoters, this result is of a greater
magnitude than the results from the first test.    It is also approximately
four-times  greater than the best results obtained by lipofection  using  the
same   plasmid.
Effect of polv-lvsine 295 (pL295).
The use of poly-lysine had an effect on both the cell growth and
transfection efficiency.    In trial #3, which used pL295, there was a 56%
increase in cell number after two days.    This figure was under one-half as
much as the over 100% increase for the other trials (table 9, figure 13).
This indicates that the use of pL295 has a negative effect on cell growth,
most  likely  by  increasing  the  amount of adenovirus  that entered  the  cells,
thus increasing the toxicity to the cells.    The increased toxicity to the cells
corresponded to an increase in efficiency of transfection.    Trial #3 was
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Table 8: LacZ Gene Expression in FA-B Lymplioblasts Transfected Via
Endocytosis-fection; Test 2.
A) 3 liour incubation in ONPG:   Efficiency of tranfection.
trial
OD at 420 nm transf.
effec.
AU
(10A.7)original correctedf
1 0.18 0.16 10.4% 0.79
2 0.12 0.09 5.9% 0.45
3 0.37 0.35 22.7% 1.73
4 0.07 0.05 3.2% 0.25
PC 1.55 1.53 100.0% 7.63
B) 16 hour incubation in ONPG: Max OD readings.
trial
OD at 420 nm AU
(10A.7)original corrected
1 0.36 0.31 1.55
2 0.24 0.19 0.93
3 0.80 0.75 3.73
4 0.15 0.10 0.48
pc 2.23 2.18 10.90
HSC 230 cells were transfected via endocytosis-fection with the iacZ containing plasmid, pH210,
under various conditions (See Materials and Methods) and an ONPG assay was initiated 48 hours
post-transfection. The optical density (OD) readings were taken (A) after 3 hours to determine the
effeciency of transfection and (B) after 16 hours which gave the maximum readings. All trials
were done using standard conditions with the exceptions of Trials #1 and 2 didn't include poiy-
lysine 295 (pL) and Trial 4 used 1/2 standard adenovirus amount and no pL HSC 93p588Z, a
normal iymphoblast cell line containing pH210 was used in the ONPG assay as the positive control
(pc), indicating 100% IacZ expression.
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TRANSFECTION EFFECIENCY OF FA-B LYMPHOBLASTS
USING ENDOCYTOSIS-FECTION: TEST #2.
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Figure 12: Effeciency of transfection of HSC 230 cells with pH210 based on
the expression of HSC 93p588Z (93-Z), a normal lymphoblast cell line
carrying the lacZ gene. #'s 1,2- no pL, #4, no pL and 1/2   amt. adenovirus.
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Table 9. Effect of Endocytosis-fection Treatment on HSC 230 Cell Growth: Test 2.
trial # DAY 0 DAY 2 X incrs. % incrs.
1 40 80 2.00 100.00
2 40 85 2.13 112.50
3 40 62.5 1.56 56.25
4 40 81 2.03 102.50
40 X 10*^5 HSC 230 cells were transfected on day 0 via endocytosis-fection. They were incubated
in complete media for 2 days and then counted again using the trypan blue exclusion assay. Live
cell numbers (given in number x 10*^5) were compared with the original cell counts and the
percentage growth calculated. Trials #1, 2 and 4 used no poiylysine 295, while trial #3 did.
EFFECT OF ENDOCYTOSIS-FECTION
ON GROWTH OF FA-B LYMPHOBLASTS.
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Figure 13: % increase in cell growth of HSC 230 cells 48 hours
post-endocytosis-fectlon. Standard conditions were used except Trials #1, 2,
and 4 used no poiylysine while Trial #3 did. Trial #4 also used 1/2 amount
of adenovirus.
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transfected at 22.0% of the control compared with 10.0% for trial #1, a
two-fold increase.    Trial #3, as well, had a corrected AU reading of 3.78 x
10-7 compared with 1.6 x 10-7  for trial #1.    This positive correlation
between the level of toxicity to the cells and efficiency of transfection, in
transfection  procedures  such  as  electroporation,  lipofection  and
endocytosis-fection is well established and is confirmed here.
Effect of adenovirus.
Trial #4 of the experiment used one-half of the amount of adenovirus
as trial #1 as well as no pL295.   There appeared to be no effect on cell
growth with the decrease in adenovirus.    This may be due to the lower
efficiency of transfection caused by the absence of pL295.    Though no effect
was seen on cell growth, there was a substantial effect in transfection
efficiency.    The low adenovirus condition had a transfection efficiency of
approximately 3.0% compared with over 10.0 % for the same conditions
but  with  the  normal  adenovirus  amount,  a three-fold reduction.
Stable   transformation   using   endocytosis-fection.
While  results  from  the transient transfection  using  this  method  have
yielded high levels of transfection efficiencies (Dr. Wang, unpublished
results,  11, 56) few tests have been carried out on the long term main¬
tenance of DNA transfected via endocytosis-fection.    In the second of the
these tests, trials #1, 3, and 4 were placed on  125 ug/ml hygromycin two
days post-transfection while trial #2 was allowed two additional days to
recover before it was also placed on hygromycin.    The results of the
selection are found in figure 14.    The cells were counted every two days
and the media was changed every 4-5 days.    After day 4 there appears to
be a slow but steady decrease in the number of live cells.    After ten days
the dead cells were removed over a ficoll cushion.    After 22 days very few
live cells remained and the experiment was aborted.    The failure to
achieve resistant coloriies may be the result of the toxicity of the
adenovirus to the cells, or it could be that the level of EBNA-1 expression
in these EBV transformed cells is too low to maintain the pH210 plasmid as
episome thus leading the loss or integration of the plasmid.    In an
alternate  experiment,  the  pH250  plasmid  was  transfected  via  endocytosis-
fection into both an XP-V fibroblast and lymphoblast cell line and high
FIGURE 14: SELECTION OF HYGROMYCIN RESISTANT FA-B
LYMPHOBLASTS TRANSFECTED VIA  ENDOCYTOSIS-FECTION.
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Figure 14: Selection for hygromycin resistance in HSC 230 cells transfected
via endocytosis-fection with pH210. Hygromycin B (100 ug/ml) was added
2 days post-transfection except trial 2 (B) which was placed on hygromycin
after 4 days. Trials 1 and 2, (A and B), were transfected under the same
conditions, (with no pL), trial 3 (C) used standard conditions and trial 4
(D) used no pL and 1/2 amount of adenovirus.
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transientlevels  of expression  were  seen.     However  when  placed  on  sel¬
ection, no resistant colonies were obtained (Dr.  S. Wang unpublished data).
SENSITIVITY ANALYSIS OF SELECTING AGENTS
One of the most important factors in finding the FA gene is the
selection, first of cells that are resistant to hygromycin B, and then to cells
which are resistant to the effect of DNA cross-linking agents.    In order to
do this, the proper concentrations of the selecting agents must be found,
concentrations that are strong enough to kill the majority of the cells but
not strong enough to kill even those cells which take-up the resistant-
bearing plasmid.    The concentration that was chosen for most of the
selection procedures is that which inhibits cell growth to  1-10% of normal
after 6 days.
Hygromycin B.
In the two major tests for hygromycin sensitivity in HSC 230 cells the
effective concentration which inhibited growth to "x" percent of normal
(ECx) were;   EC 50 = 30 ug/ml, EC 10 = 100 ug/ml and the EC 1 = 120
ug/ml.     100-125  ug /ml were used to select for plasmids transfected into
HSC 230 cells (figure 15).
MMC sensitivity.
Figure 16A shows the sensitivity to MMC of four FA lymphoblasts cell
lines as well as two normal lymphoblasts cell lines.    These confirm what
has been shown before, namely that, of the FA cell lines, HSC 62 (FA-D) is
the least sensitive among the four FA cell lines, having a sensitivity close
to that of the normal cell line HSC 93 (the former has an EClO of 55-65
ng/ml while the latter has one of over  100 ng/ml, a 2-4 times difference),
that HSC's 72 and 99 (FA-A) cell lines have an intermediate sensitivity
which are similar to each other, and finally that HSC 230 (FA-B) is the
most sensitive (27, 51).   The EC 10 for HSC 230 is around 10 nM.   This is
the concentration that will be used when the library is established (table
10).
PUVA  sensitivity:
Figure 16B shows the sensitivity to HMT and UVA light (PUVA) of the
six aforementioned cell lines.    The results are in line with other sensitivity
studies done using PUVA on FA cells (39).   The FA cell lines show a similar
pattern of sensitivity relative to each other as was the case with MMC,
SENSITIVITY OF FA-B
LYMPHOBLASTS TO HYGROMYCIN B.
63
100
o
o>
^
-Q------     STUDY 1
-*------     STUDY 2
200
concentration    (ug/ml)
Figure 15: Effect of hygromycin B on growth of HSC 230 cells in two independent
studies. Cells were initially exposed to hygromycin B on day 0 and then counted on
day 6.
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^^Bble 10: Effect on Growth of FA Lymphoblasts Treated with DNA Cross-linking Agents.
(A)   MMC Sensitivity
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CELL LINE GROUP EC 50 EC10
X Normal CBDt CBD
HSC93 Normal 26 C8D
HSC72 FA-A < 4.00 45.00
HSC99 FA-A < 4.00 55-65
HSC 230 FA-B < 4.00 10.00
HSC62 FA-D 12.00 55-90
(B) PUVA Sensit vity
CELL LINE GROUP EC 50 EC10 EC1
UC Normal CBDt CBD CBD
HSC 93 Normal 10 55 75
HSC 72 FA-A 1.00 2.00 3.50
HSC 99 FA-A 1.00 2.00 3.50
HSC 230 FA-B < 0.25 < 0.50 < 0.50
HSC 62 FA-D 1.50 3.50 7.00
Table 10: Sensitivity of four FA cell lines to the cross-linking agents; (A) mitomycin C (MMC) in
nM and (B) psoralen and UVA light (PUVA) in ng/ml. 1.0 and 2.0 x 10*^5 cells respectively for A
and B were seeded into each well of a 24 well plate. Each column was then treated with
progressively higher doses of the cross-linking agent. ECx = effective concentration needed to
reduce cell growth to "x" % of normal. The UC cell line is not sensitive to the cross-linking
agents at the concentrations administered, therefore the EC50 and EC10 could not be determined,
(CBD).
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SENSITIVITY OF FA LYMPHOBLASTS TO DNA CROSSLINKING AGENTS.
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Figure 16: Sensitivity of four FA lymphoblasts to; (A), HMT (psoralen) and
UVA light (PUVA), and (B) to mitomycin 0 (MMC). UC and HSC 93 are normal
lymphoblasts while HSC's 72, 99, 230, and 62 belong to FA groups A, A, B, and D
respectively.
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though they, as a whole, exhibit a much greater sensitivity than with MMC
relative to the normal cell lines (table 10).   The EClO of HSC 62, the least
sensitive of the FA cell lines, is approximately 4.5 ng/ml while the EC 10 of
the most sensitive normal cell line was over 65 ng/ml, almost  15  times
greater.    There was only, at most, only a four times difference between the
sensitivities of HSC 62 and HSC 93 to MMC.   The FA-B cell line showed
extreme sensitivity to PUVA treatment having an EC  10 of under 0.5
ng/ml.
DISCUSSION
In the quest to discover the most efficient method to transfect an entire
cDNA library into FA-B cells, three different transfection methods were
explored   including  electroporation,  lipofection   and  endocytosis-fection
(figure   17).    While transient results were obtained which would indicate
that stable transfection could take place, this result failed to occur.
Electroporation gave consistently poor results and was dropped from
consideration.    Using lipofection, lacZ expression readings of over 1.0 x 10-'^
AU's per cell were obtained using the SV40-driven lacZ plasmid (pH210)
on the FA-B lymphoblast cell line, HSC 230.    This number is 2-3 times
higher than the best result obtained via electroporation and four times less
than lacZ expression levels obtained via endocytosis-fection.    With a lower
lacZ expression, (0.15 x 10-^ AU's per cell), the pDR2 plasmid was
successfully transfected,  using lipofection, into an FA-A lymphoblast cell
line, HSC 72.    However, as mentioned, this result has not been duplicated in
the FA-B cell line.    This result would indicate cell line differences in stable
transfection efficiencies, with the FA-B  lymphoblast cell line apparently
needing a higher level of DNA-transfer in order to stably maintain the
plasmid.    The reason for this may involve the inherently greater genetic
instability of FA lymphoblasts from group B as compared to group A as
seen  in  the  cross-link  sensitivity  analysis  and  chromosome  aberration
studies.    It may also concern the fact that the FA group B lymphoblast (HSC
230) grows at a slower rate than does those from group A (HSC's 72, and
99).    It should be noted that the group C lymphoblast cell line, HSC 536,
which has been cloned, though genetically the most unstable of the
established and characterized FA lymphoblast cell lines, has the highest
rate of growth among each of these lines, [52, personal  observation ]) .
^^
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The highest efficiency of transfection of the FA-B lymphoblast cells,
based on expression of the lacZ gene, was found using endocytosis-fection.
Using the pH210 plasmid, an expression level of about 4.0 x lO-^ AU's per
cell (approximately a 20% transfection efficiency) was obtained.    This
number is almost four times higher than the best result obtained using
lipofection.    However, no resistant colonies were obtained when these cells
were placed on hygromycin.    The failure to achieve a stable transformation
of the FA-B cells as well as the XP cells transfected with either pH210 or
pH250 could be due to either the nature of the plasmids and/or of some
component  of the  endocytosis-fection  method.
The former hypothesis is supported by the fact that when two different
cell lines, one fibroblast and one lymphoblast, were transfected with the
cDNA library pDR2, (containing the EBNA-1 gene and RSV promotor), along
with the mini-EBV lacZ plasmids pH210 and pH250, only lymphoblast cells
receiving the cDNA plasmid became hygromycin resistant, while in the
fibroblast, resistant colonies were obtained with the lacZ constructs, though
at a much lower number than with the pDR2 (personal   observation).
There are both experimental and theoretical  support for the latter
hypothesis.    Experimentally, the lacZ construct pH250 was transfected at a
high efficiency (as determined by the ONPG assay) in human XP cells via
endocytosis-fection and then placed on selection in hygromycin, yet no
resistant colonies were obtained.    This failure, as well as the one with the
FA-B lymphoblasts, may be due to the toxicity of the adenovirus to the
cells.    When the adenovirus is rendered replication defective by psoralen
and UVA light, its titer is not totally abolished(ll, 12)    and replication of
the adenovirus at a high enough level would be lethal to the cells.
Adenovirus's are also known to recombine with endogenous cell virus's to
once again become replication-competent.    Additionally, it has been
reported that the penton protein found in the capsid of the adenovirus is
also toxic to mammalian cells (9).
Alternately,  the  great amount of endocytosis  that invariably  occurs
following the binding of the adenovirus-DNA complex    to the numerous
adenovirus receptors on the surface of many cells, may be a shock to the
cell system too great for the cells to handle and thus may lead to cell
death.
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In  the  effort to achieve  the  most efficient transfection  protocol  using
endocytosis-fection  a few experiments  were attempted.     In  the  first
experiment,  the  lymphoblast cells  were  exposed  to the  compound
desferrin,  which  induces  the production  of transferrin  receptors  on  the
surface of many cells (11, 12, 58).   In many monolayer cell lines this action
resulted in an increase in transfection efficiency.     However,  the desferrin,
at the dose given, proved toxic to the FA and XP lymphoblast cells and so
whose result could  not  accurately  be determined.
In another of the experiments, the poly-lysine 295,  which is  added to
the DNA-Adenovirus conjugate after the DNA and which, along with the
transferrin poly-lysine causes the folding of the DNA into a "doughnut
shape", was omitted three of the trials (figure 6).    This resulted in two-fold
decrease in the lacZ expression underlying the importance of this
component to the process.
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MAXIMUM TRANSFECTION  LEVELS OF FA-B  LYMPHOBLASTS
USING THREE DIFFERENT TRANSFECTION METHODS.
H   Endocytosls
H   Lipofection
ͣ   Eiectp.
SV40-lacZ CMV-lacZ
Promotor  driving  the  iacZ  gene.
Figure 17:   HSC 230 (FA-B) cells were transfected via electroporation,
lipofection and endocytosis-fection, with reporter plasmids driven by
two different promoters.
g-^^^-S^s^p-
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CHAPTER Vn: CONCLUSIONS AND RECOMMENDATIONS-PROJECT 2
The objectives for the first part of this study, to determine the most
efficient method of transfection for cells belonging to Fanconi's anemia
group B  cells,  was partially achieved,  though more work remains to be
done.
The FA-B lymphoblastoid cells have proved resistant to the uptake and
stable  maintenance  of certain  plasmids  transfected  through
electroporation,  lipofection,  and  endocytosis-fection.     Transiently,  the
efficiencies of transfection by electroporation have proved too low to be
feasible as a choice to insert the cDNA library, though selection for long
term maintenance of transfected plasmids  was tried and failed  in these
ceils using this method.    Transfection by lipofection has yielded better
transient  results   than  with  electroporation   though   stable  transformation   of
FA-B lymphoblast cells has also proved elusive.    The FA-A lymphoblastoid
cell line, HSC 72, however, was able to be stably transformed with the
pDR2 cDNA library using lipofection.
A novel transfection system, endocytosis-fection, was found to yield a
four times greater signal in HSC 230 cells than with the other methods.
Though transient transfection efficiencies are high, questions remain  as to
whether a plasmid transfected by this method can be stably maintained as
well as can any plasmid be maintained in this specific cell line.    In at least
two transfection experiments involving FA and XP cells, selection of the
transfected plasmid could not be achieved despite high transient level of
expression of the plasmid.    Alternatively, while resistant colonies were
obtained in an FA group A lymphoblast cell line at a transient lacZ
expression level of approximately 0.15 x  10-7 AU's/cell, using lipofection,
no such resistance could be obtained in the group B lymphoblasts despite
levels of expression almost 4-5 times higher than this.
The insertion of a cDNA library into FA cells stands as the major
obstacle in the cloning of the gene.   Besides a complete cDNA library, a cell
line which can take up plasmid DNA and an efficient method of
transfection are also needed.    The only fully transformed FA-B
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lymphoblast cell  line  that has  been characterized  (HSC 230)  has proved
resistant to the uptake of foreign DNA using three different methods of
transfection.     Using   the   novel   adenovirus-assisted,   endocytosis-mediated
system of transfection, plasmid DNA can be transferred into these cells at a
relatively high rate though once in the cells, the DNA can not be
maintained.    This may indicate a deficiency with this transfection system
as it presently  stands though modifications have been proposed  which
may overcome this deficit.    Once a library has been successfully been
established in a FA cell line, selecting for the gene is a relatively
straightforward  procedure,  though  success  in  this  venture  also depends  on
the quality of the library and the presence of the intact FA gene among the
cDNA.    If efficient ways can be found to insert the library into the FA-B
cells, then it is a matter of time before the gene will be cloned.
Recommendations  for  Future  Research.
The  endocytosis-mediated  method  of transfection  may  be  the  most
promising system to achieve the goal of the insertion of a cDNA library
into FA-B lymphoblast cells, and hence to progress further in the cloning of
the FA-B gene if modifications can be found which render the method less
toxic to the cells.    It remains to be seen if a plasmid transfected in this
manner can be stably maintained in the FA-B cell line.    In order to test
this out,  the following experiments should be performed.
First, HSC 230 cells should be transfected with the pDR2 cDNA library
and  pH210 using endocytosis-fection under the  same conditions  that  were
used in trial #3 in test #2 of the endocytosis-fection experiments, and
placed under selection with hygromycin B, (if the transient signal was
comparable to the earlier levels).    If resistant colonies can be selected,
then this would demonstrate that plasmid DNA can be transfected and
stably maintained in a cell line using the endocytosis-fection method.    It
would also show that the previous failure of selection using pH210 was at
least partially due to the nature of the plasmid and not solely on the
method of transfection.    If this were the case then steps would be taken to
establish the whole cDNA library into these cells.
If resistant colonies could not be selected, even after high transient lacZ
expression and use of the pDR2 plasmid, this would indicate that some
portion of the experiment was toxic to the cells, either the large amount of
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endocytosis  that occurs from the massive binding  of the  adenovirus  or of
some component of the adenovirus itself.    One way to test the former
hypothesis  would  be  to repeat the experiment with  both  a lymphoblast
and a fibroblast cell line known to transfect easily (such as the XP-V cell
lines used by Dr. S. Wang), using the pH210 and pDR2 plasmids decreasing
the amount of conjugate used, in the hopes of finding an optimal
concentration that yielded  a relatively  strong lacZ signal and hygromycin
resistant cells.    If decreasing the amount of conjugate (and hence amount
of adenovirus) resulted in a increased  number of hygromycin  resistant
cells, this would support the former hypothesis.    If no resistant colonies
could be obtained, even using low amount of conjugate, this would support
the   latter  hypothesis.
Recent  endocytosis-mediated   transfection  experiments   have   been
performed using a chicken-derived adenovirus (CELO) as a substitute to
the human adenovirus.    Positive results have been found both in the short
term expression of reporter plasmids but also in long-term selection of
plasmid DNA (personal communication. Dr. Gotten).    Use of this new
adenovirus  should be pursued to see if the obstacle encountered to date
can be overcome.
With  the knowledge  that fibroblasts  are more  efficiently  transfected
using  lipofection  or endocytosis-fection  than  are  lymphoblastoid  cells,
transfection work should also be continued on the FA-B partially
transformed  fibroblast,  HSCl 199-11-2  to  see  if hygromycin  resistant
colonies can be established using the pDR2 library transfected via either
lipofection or endocytosis-fection  (with either human  or chicken
adenovirus).    Also, if the cloning of the FA group B gene is to be cloned
then steps should be taken as well to locate alternate cell lines which are
more  transfectable,  preferable fully transformed  fibroblasts,  which  are,  in
general easier to transfect (with  such methods as lipofection) than are
lymphoblasts.
r=tt-^tii^^^Jtl}fi^.^-. ..Ittjt;
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